| SIB Home page | Computational Cancer Genomics | Swiss EMBnet node | ExPASy | ISREC |
| CleanEx Tutorial |
| Organism | PLatform Type | Dataset | Description of experiment | Medline | Documentation file |
|---|---|---|---|---|---|
| Human 642 | AFFY 479 | A0001 | Oligonucleotide array data for tumor and normal colon tissues | 10359783 | A0001_DOC |
| AFFY004 | Molecular Classification of Human Carcinomas | 11606367 | AFFY004_DOC | ||
| GSE1000 | Osteosarcoma TE85 cell tissue culture study | GSE1000_DOC | |||
| GSE1004 | Molecular profiles (HG-U95A) of dystrophin-deficient and normal human muscle | 12415109 | GSE1004_DOC | ||
| GSE10072 | Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival | GSE10072_DOC | |||
| GSE1007A | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007A_DOC | ||
| GSE1007B | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007B_DOC | ||
| GSE1007C | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007C_DOC | ||
| GSE1007D | Molecular profiles(HG-U95B,C,D,E) of dystrophin-deficient and normal human skeletal muscle | 12698323 | GSE1007D_DOC | ||
| GSE1009 | Diabetic nephropathy | 15042541 | GSE1009_DOC | ||
| GSE1010 | FCHL study | GSE1010_DOC | |||
| GSE1017 | Acute Quadriplegic Myopathy | GSE1017_DOC | |||
| GSE1036 | Hemin timecourse 0-72h | 15252187 | GSE1036_DOC | ||
| GSE1045 | Estradiol Treated Breast Cancer Cells Expressing Mutant Estrogen Receptors | 15023342 | GSE1045_DOC | ||
| GSE1056 | Hypoxia and Hypoxia mimics | 15942021 | GSE1056_DOC | ||
| GSE1059 | Myometrial cells expressing CREB, CREM alpha, CREM tau2alpha, ATF2 or the ATF2-small gene | 15691874 | GSE1059_DOC | ||
| GSE1081 | Effect of a 4 hour treatment of 100 nM endothelin-1 on human primary lung fibroblasts | 15044479 | GSE1081_DOC | ||
| GSE1122 | Emphysema Lung Tissue Gene Expression Profiling | 15284076 | GSE1122_DOC | ||
| GSE1124 | Comparison between uncomplicated and severe malaria and between both and health | GSE1124_DOC | |||
| GSE1132A | IFN-Gamma keratinocytes | 15145801 | GSE1132A_DOC | ||
| GSE1132B | IFN-Gamma keratinocytes | 15145801 | GSE1132B_DOC | ||
| GSE1133A | tissue-specific pattern of mRNA expression | 15075390 | GSE1133A_DOC | ||
| GSE1140 | PMBCs and the effect of exercise | 15194674 | GSE1140_DOC | ||
| GSE1141 | Inflammatory bowel disease (HG-U133A) | GSE1141_DOC | |||
| GSE1142 | Inflammatory bowel disease (HG-U133B) | GSE1142_DOC | |||
| GSE1144 | aging of cultured human myotubes | GSE1144_DOC | |||
| GSE1145A | changes in cardiac transcription profiles brought about by heart failure | GSE1145A_DOC | |||
| GSE1145B | changes in cardiac transcription profiles brought about by heart failure | GSE1145B_DOC | |||
| GSE1147 | Sex Specific Transciption in Human Hypothalamus | GSE1147_DOC | |||
| GSE1152A | Inflammatory bowel disease | GSE1152A_DOC | |||
| GSE1152B | Inflammatory bowel disease | GSE1152B_DOC | |||
| GSE1153 | Estrogen-regulated gene expression in human osteosarcoma cells stably transfected with estrogen receptor alpha or beta | 15033914 | GSE1153_DOC | ||
| GSE1158 | Wilms tumor versus Stratagene Universal Reference | GSE1158_DOC | |||
| GSE1159 | Expression profiles of acute myeloid leukemia patient samples | 15084694 | GSE1159_DOC | ||
| GSE121A | Type 2 diabetes and insulin resistance | 12436343 | GSE121A_DOC | ||
| GSE121B | Type 2 diabetes and insulin resistance | 12436343 | GSE121B_DOC | ||
| GSE121C | Type 2 diabetes and insulin resistance | 12436343 | GSE121C_DOC | ||
| GSE121D | Type 2 diabetes and insulin resistance | 12436343 | GSE121D_DOC | ||
| GSE121E | Type 2 diabetes and insulin resistance | 12436343 | GSE121E_DOC | ||
| GSE1264 | Sindbis survivors | GSE1264_DOC | |||
| GSE1277 | HGPC, in monolayer, 0.5 vs. 20% serum | 15094393 | GSE1277_DOC | ||
| GSE1278 | HGPC, in monolayer, 0.5% serum | 15094393 | GSE1278_DOC | ||
| GSE1295A | STRRIDE Study | 15347626 | GSE1295A_DOC | ||
| GSE1295B | STRRIDE Study | 15347626 | GSE1295B_DOC | ||
| GSE1296 | Simple ambient preservation of human tissues for RNA expression array analysis | 15537428 | GSE1296_DOC | ||
| GSE1297 | Incipient Alzheimer's Disease: Microarray Correlation Analyses | 14769913 | GSE1297_DOC | ||
| GSE1299A | Breast Cancer Cell Line Experiment | 15161944 | GSE1299A_DOC | ||
| GSE1299B | Breast Cancer Cell Line Experiment | 15161944 | GSE1299B_DOC | ||
| GSE1299C | Breast Cancer Cell Line Experiment | 15161944 | GSE1299C_DOC | ||
| GSE1300 | Hereditary Spastic Paraparesis | GSE1300_DOC | |||
| GSE1302A | primary trophoblast study | 15161964 | GSE1302A_DOC | ||
| GSE1302B | primary trophoblast study | 15161964 | GSE1302B_DOC | ||
| GSE1302C | primary trophoblast study | 15161964 | GSE1302C_DOC | ||
| GSE1302D | primary trophoblast study | 15161964 | GSE1302D_DOC | ||
| GSE1302E | primary trophoblast study | 15161964 | GSE1302E_DOC | ||
| GSE1309 | Gene expession profiles for monoclonal cell lines with high or low levels of store-operated Ca2+ entry. | 15623568 | GSE1309_DOC | ||
| GSE1317 | Ultraviolet induced gene expression in human basal cell culture | GSE1317_DOC | |||
| GSE1318A | Myb specificity determinants | 15105423 | GSE1318A_DOC | ||
| GSE1318B | Myb specificity determinants | 15105423 | GSE1318B_DOC | ||
| GSE1323 | Isogenic primary tumor/metastasis comparison | 16531451 | GSE1323_DOC | ||
| GSE1343 | Burn/Trauma Study | 15548831 | GSE1343_DOC | ||
| GSE1347 | Pre-analytical changes of mRNA Gene Expression as the result from prolonged storage | 15238145 | GSE1347_DOC | ||
| GSE1364 | Long-Term Storage of Human Cells at Ambient Temperature | 16155929 | GSE1364_DOC | ||
| GSE1377 | Kaposi's sarcoma-associated herpes virus | 15220917 | GSE1377_DOC | ||
| GSE1397 | Trisomy 21 and TS13 | 16420667 | GSE1397_DOC | ||
| GSE1400 | MCF-7 Fractionated RNA | 15574777 | GSE1400_DOC | ||
| GSE1402 | Juvenile Rheumatoid Arthritis Profiles In PBMC and SFMC | 15150433 | GSE1402_DOC | ||
| GSE1403 | Cyclosporine A timecourse 0, 12, 48 hours | 16049326 | GSE1403_DOC | ||
| GSE1407 | HIV-based vector infected cells | 15314653 | GSE1407_DOC | ||
| GSE1410 | ASLV vector infected 293t-TVA cells | GSE1410_DOC | |||
| GSE1417 | Untreated vs. Camptothecin Treated HeLa cells | 15026349 | GSE1417_DOC | ||
| GSE1418 | Imatinib effects on CD34+ cells | 15618956 | GSE1418_DOC | ||
| GSE1420 | Barrett's esophagus, Barrett's-associated adenocarcinomas and normal esophageal epithelium | 15833844 | GSE1420_DOC | ||
| GSE1427A | Expression profiles in Blast Bank samples with AML/RAEB | GSE1427A_DOC | |||
| GSE1427B | Expression profiles in Blast Bank samples with AML/RAEB | GSE1427B_DOC | |||
| GSE1428 | Skeletal muscle sarcopenia | 15687482 | GSE1428_DOC | ||
| GSE1431 | Human prostate cancer tissues analyses | GSE1431_DOC | |||
| GSE1432 | Transcriptional Response of Human Microglial Cells to Interferon-gamma | 16163375 | GSE1432_DOC | ||
| GSE1455 | Two week Storage and Rehydration of HEK 293 Cells at Ambient Temperature | 16155929 | GSE1455_DOC | ||
| GSE1456A | Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients | 16280042 | GSE1456A_DOC | ||
| GSE1456B | Gene expression of breast cancer tissue in a large population-based cohort of Swedish patients | 16280042 | GSE1456B_DOC | ||
| GSE1460A | Gene Expression Profile during human CD4+ T cell differentiation | 15210650 | GSE1460A_DOC | ||
| GSE1460B | Gene Expression Profile during human CD4+ T cell differentiation | 15210650 | GSE1460B_DOC | ||
| GSE1462 | Mitochondrial disorders | 15728662 | GSE1462_DOC | ||
| GSE1466A | Expression profiles of ATL patients | GSE1466A_DOC | |||
| GSE1466B | Expression profiles of ATL patients | GSE1466B_DOC | |||
| GSE1469 | A549 lung pneumocytes cell line infected with wildtype and deletion mutation PAK strain Pseudomonas aeruginosa | 16207250 | GSE1469_DOC | ||
| GSE1470 | Epithelial stem cells co-cultured with the dermal papilla | 15292489 | GSE1470_DOC | ||
| GSE1473 | Beta-catenin/GFP | GSE1473_DOC | |||
| GSE1474 | Caco-2 and T84 cells stimulated with with flagellin, lymphotox beta or TNF alpha | GSE1474_DOC | |||
| GSE1481 | LCCS vs control comparison | 16155903 | GSE1481_DOC | ||
| GSE1485 | Natural variation in human gene expression | 15269782 | GSE1485_DOC | ||
| GSE1493 | Hematopoietic stem cell subsets | 15790771 | GSE1493_DOC | ||
| GSE1518 | Human endothelium exposed to shear stress and pressure | 16155357 | GSE1518_DOC | ||
| GSE1541 | A549 parenchymal cell activation | 15454581 | GSE1541_DOC | ||
| GSE1542A | Expression profile of pancreatic ductal cells | 16053509 | GSE1542A_DOC | ||
| GSE1542B | Expression profile of pancreatic ductal cells | 16053509 | GSE1542B_DOC | ||
| GSE1551 | dermatomyositis | 15852401 | GSE1551_DOC | ||
| GSE1561 | EORTC 10994 clinical trial | 15897907 | GSE1561_DOC | ||
| GSE1562 | Adenovirus-mediated E2F-1 gene transfer in melanoma cell line | 15656974 | GSE1562_DOC | ||
| GSE1563 | Kidney Transplant Rejection and Tissue Injury by Gene Profiling of Biopsies and Peripheral Blood Lymphocytes | 15307835 | GSE1563_DOC | ||
| GSE1572 | Gene regulation and DNA damage in the aging human brain | 15190254 | GSE1572_DOC | ||
| GSE1577 | T-ALL and T-lymphoblastic lymphoma | 16358311 | GSE1577_DOC | ||
| GSE1595 | Human bladder smooth muscle cells - effect of stretch in vitro | 15467014 | GSE1595_DOC | ||
| GSE1614 | Caco-2 differentiation | 12644633 | GSE1614_DOC | ||
| GSE1615A | Theca cell gene expression | 15598877 | GSE1615A_DOC | ||
| GSE1615B | Theca cell gene expression | 15598877 | GSE1615B_DOC | ||
| GSE1629 | Carious versus healthy pulp gene expression | 15869869 | GSE1629_DOC | ||
| GSE1643 | Normal Variance of Gene Expression in the Human Lung | 16498083 | GSE1643_DOC | ||
| GSE1644 | Leukotriene D4-triggered Transcriptome | 15322539 | GSE1644_DOC | ||
| GSE1648 | Osmotic Loading of Human Intervertebral Disc Cells | GSE1648_DOC | |||
| GSE1650 | COPD Study | 15374838 | GSE1650_DOC | ||
| GSE1657A | Adipocyte Differentiation | GSE1657A_DOC | |||
| GSE1657B | Adipocyte Differentiation | GSE1657B_DOC | |||
| GSE1676 | DNA damage response (NCS treatment) in several siRNA-manipulated cellular systems | 15892871 | GSE1676_DOC | ||
| GSE1682 | Global gene expression analysis of human glioma (Hs 683) cell lines exposed to candoxin | 16309724 | GSE1682_DOC | ||
| GSE1692 | T98G growth arrest | 15525513 | GSE1692_DOC | ||
| GSE1703 | Determination of mRNA transcripts in HeLa cells that are regulated by RENT1 | 15448691 | GSE1703_DOC | ||
| GSE1709 | STS107 T-cell activation at 1g vs. vg | 16210397 | GSE1709_DOC | ||
| GSE1719 | Macular Degeneration | GSE1719_DOC | |||
| GSE1724 | TGFbeta lung fibroblasts | GSE1724_DOC | |||
| GSE1725 | Toxicity from radiation therapy associated with abnormal transcriptional responses to DNA damage | 15096622 | GSE1725_DOC | ||
| GSE1729 | Gene expression profile of acute myeloid leukemia | 15674361 | GSE1729_DOC | ||
| GSE1739 | SARS | GSE1739_DOC | |||
| GSE1740 | Tassiulas IFN Array v1.0 | 15467722 | GSE1740_DOC | ||
| GSE1743 | De novo kidney transplantation without use of calcineurin inhibitors preserves renal structure and function | GSE1743_DOC | |||
| GSE1746 | CD14+ cell analysis | GSE1746_DOC | |||
| GSE1751 | Human blood expression for Huntington's disease versus control | 16043692 | GSE1751_DOC | ||
| GSE1764A | Effect of Oxandrolone on Muscle in Duchenne Muscular Dystrophy | 16263771 | GSE1764A_DOC | ||
| GSE1764B | Effect of Oxandrolone on Muscle in Duchenne Muscular Dystrophy | 16263771 | GSE1764B_DOC | ||
| GSE1786 | Vastus lateralis biopsies from healthy trained and sedentary males | 16260967 | GSE1786_DOC | ||
| GSE1789 | heart gene expression in Down syndrome | GSE1789_DOC | |||
| GSE1792 | Melanoma progression model: Differential Gene Expression | 15958521 | GSE1792_DOC | ||
| GSE1793 | Melanoma progression model:DAC-mediated gene expression | 15958521 | GSE1793_DOC | ||
| GSE1801 | Human hematopoietic stem cell engraftment in goat | 16682618 | GSE1801_DOC | ||
| GSE1802 | CBCD34-TGFbeta targets | 15477587 | GSE1802_DOC | ||
| GSE1805 | TGFbeta targets in M091 cell line | 15477587 | GSE1805_DOC | ||
| GSE1815 | The Influence of Interferon Gamma on Gene Expression in Normal Human Bronchial Epithelial Cells | 15985639 | GSE1815_DOC | ||
| GSE1822 | EWS-FLI1-transfection of HEK293 | 15548687 | GSE1822_DOC | ||
| GSE1823 | IL-2 transfection of A673-cells | 15170886 | GSE1823_DOC | ||
| GSE1824 | Neuroblastoma cell lines | 15548687 | GSE1824_DOC | ||
| GSE1825 | SRBCT | 15548687 | GSE1825_DOC | ||
| GSE1832 | Time and Exercise effects on Human Skeletal Muscle | 14519196 | GSE1832_DOC | ||
| GSE1845 | Melanoma cell lines | 15967107 | GSE1845_DOC | ||
| GSE1848A | lung and tonsillar mast cells | 15470070 | GSE1848A_DOC | ||
| GSE1848B | lung and tonsillar mast cells | 15470070 | GSE1848B_DOC | ||
| GSE1849A | Differential Gene Expression in Pulmonary Artery Endothelial Cells Exposed to Sickle Cell Plasma | 15741505 | GSE1849A_DOC | ||
| GSE1849B | Differential Gene Expression in Pulmonary Artery Endothelial Cells Exposed to Sickle Cell Plasma | 15741505 | GSE1849B_DOC | ||
| GSE1862 | The search for enzymes responsible for metabolism of nucleoside analogs | GSE1862_DOC | |||
| GSE1869 | Ischemic and Nonischemic CM and NF Hearts | 15769906 | GSE1869_DOC | ||
| GSE1880 | Role of LANA in KSHV latent infection | 15525642 | GSE1880_DOC | ||
| GSE1907 | Sarcoidosis + Follow-up study | GSE1907_DOC | |||
| GSE1910 | Microarray analysis of activated mixed glial (microglia) and monocyte-derived macrophage gene expression. | 15579277 | GSE1910_DOC | ||
| GSE1919 | Rheumatoid arthritis | GSE1919_DOC | |||
| GSE1922 | Leukemia study / K562 cell line | GSE1922_DOC | |||
| GSE1923 | Identification of PDGF-dependent patterns of gene expression in U87 glioblastoma cells | 15994924 | GSE1923_DOC | ||
| GSE1925 | IFN-gamma priming | 16148108 | GSE1925_DOC | ||
| GSE1926 | Carboplatin Sensitivity in Ovarian Carcinoma | 16227411 | GSE1926_DOC | ||
| GSE1933 | Mast Cell_time series | 16911805 | GSE1933_DOC | ||
| GSE1937 | Collagen-GAG Biocompatibility Tests | GSE1937_DOC | |||
| GSE1955 | Gene expression changes induced by K-ras oncogene in the human pancreatic duct epithelial cell line (H6c7) | GSE1955_DOC | |||
| GSE1977 | Portrait of transcriptional responses to ultraviolet and ionizing radiation in human cells | 15356296 | GSE1977_DOC | ||
| GSE1982 | PBMCs from CCI-779 Treated RCC subjects | GSE1982_DOC | |||
| GSE1987 | Non Small Cell Lung Cancer | GSE1987_DOC | |||
| GSE2004 | scien-affy-human-87089 | GSE2004_DOC | |||
| GSE2006 | Comparative microarray between normal and essential thrombocythemia platelets | 16113833 | GSE2006_DOC | ||
| GSE2018 | Human Lung Transplant - BAL | GSE2018_DOC | |||
| GSE2034 | Breast cancer relapse free survival | 15721472 | GSE2034_DOC | ||
| GSE2040 | Human endothelial progenitor cells (EPC) vs. human umbilical vein endothelial cells (HUVEC) vs. CD14+ monocytes | 15665831 | GSE2040_DOC | ||
| GSE2044A | Combining gene expression data from different generations of oligonucleotide arrays | 15504239 | GSE2044A_DOC | ||
| GSE2044B | Combining gene expression data from different generations of oligonucleotide arrays | 15504239 | GSE2044B_DOC | ||
| GSE2049 | AML1-ETO target genes | 15731354 | GSE2049_DOC | ||
| GSE2060B | Characterize CREB target genes in different tissue types | 15753290 | GSE2060B_DOC | ||
| GSE2060C | Characterize CREB target genes in different tissue types | 15753290 | GSE2060C_DOC | ||
| GSE2067 | HCV_Core_Study | 16876223 | GSE2067_DOC | ||
| GSE207 | HDMTX_MP-1 pair | 12704389 | GSE207_DOC | ||
| GSE2077 | Gene expression in Cryptosporidium parvum-infected human ileocecal adenocarcinoma cells (HCT-8) | 14711592 | GSE2077_DOC | ||
| GSE208 | HDMTX_MP-10 pair | 12704389 | GSE208_DOC | ||
| GSE209 | HDMTX_MP-2 pair | 12704389 | GSE209_DOC | ||
| GSE2099 | control-ethanol liver RNA | 15705656 | GSE2099_DOC | ||
| GSE210 | HDMTX_MP-3 pair | 12704389 | GSE210_DOC | ||
| GSE2109 | Expression Project for Oncology (expO) | GSE2109_DOC | |||
| GSE211 | HDMTX_MP-4 pair | 12704389 | GSE211_DOC | ||
| GSE2110 | Marrow-derived Mesenchymal stem cells(2004/12/24) | 15923633 | GSE2110_DOC | ||
| GSE2111 | Metal and Gene Expression | 16330358 | GSE2111_DOC | ||
| GSE2113 | Plasma cell dyscrasias expression profiles associated with distinct IGH translocations in multiple myeloma | 15735737 | GSE2113_DOC | ||
| GSE2117 | CALM-AF10 T-ALL | 16107895 | GSE2117_DOC | ||
| GSE212 | HDMTX_MP-5 pair | 12704389 | GSE212_DOC | ||
| GSE2125 | isolated alveolar macrophages | 16166618 | GSE2125_DOC | ||
| GSE213 | HDMTX_MP-6 pair | 12704389 | GSE213_DOC | ||
| GSE2135 | Filaria induced monocyte dysfunction and its reversal following treatment | 16861626 | GSE2135_DOC | ||
| GSE2138A | Colon cancer profiling | 16247484 | GSE2138A_DOC | ||
| GSE2138B | Colon cancer profiling | 16247484 | GSE2138B_DOC | ||
| GSE214 | HDMTX_MP-7 pair | 12704389 | GSE214_DOC | ||
| GSE2144 | Gene induction by low pH in oesophageal cells | 16113055 | GSE2144_DOC | ||
| GSE2149 | Gene Expression Profile of Primary Effusion Lymphoma | GSE2149_DOC | |||
| GSE215 | HDMTX_MP-8 pair | 12704389 | GSE215_DOC | ||
| GSE2152 | The effect of FH mutations on fibroid expression profile | 16319128 | GSE2152_DOC | ||
| GSE216 | HDMTX_MP-9 pair | 12704389 | GSE216_DOC | ||
| GSE2164 | Gender-specific gene expression in post-mortem human brain | 14583743 | GSE2164_DOC | ||
| GSE217 | HDMTX-1 pair | 12704389 | GSE217_DOC | ||
| GSE2171 | HIV-1 infection in human PBMCs in vivo | 15897992 | GSE2171_DOC | ||
| GSE2174 | D4-ME effects | GSE2174_DOC | |||
| GSE2175 | Differential gene expression in pituitary adenomas by oligonucleotide array analysis | 15994756 | GSE2175_DOC | ||
| GSE218 | HDMTX-10 pair | 12704389 | GSE218_DOC | ||
| GSE2189 | A549 teatement with MGd | GSE2189_DOC | |||
| GSE219 | HDMTX-11 pair | 12704389 | GSE219_DOC | ||
| GSE2191 | pediatric AML and normal bone marrow | 12738660 | GSE2191_DOC | ||
| GSE220 | HDMTX-12 pair | 12704389 | GSE220_DOC | ||
| GSE2208 | gene expression study of blood monocytes | 15965235 | GSE2208_DOC | ||
| GSE221 | HDMTX-13 pair | 12704389 | GSE221_DOC | ||
| GSE222 | HDMTX-14 pair | 12704389 | GSE222_DOC | ||
| GSE2222 | FoxM1 siRNA profiles | 15958562 | GSE2222_DOC | ||
| GSE2225 | Letrozole-, Anastrozole- and Tamoxifen-Responsive Genes in MCF-7aro Cells | 15831674 | GSE2225_DOC | ||
| GSE223 | HDMTX-15 pair | 12704389 | GSE223_DOC | ||
| GSE2230 | Effects of hTERT overexpression on gene expression profiles in CD4+ T lymphocytes | 15741219 | GSE2230_DOC | ||
| GSE2232 | Caco-2 cells cocultured with E.coli Nissle 1917 | 16351713 | GSE2232_DOC | ||
| GSE2238 | Targets of cytostatic drugs in HT1080 fibrosarcoma | 16001973 | GSE2238_DOC | ||
| GSE224 | HDMTX-16 pair | 12704389 | GSE224_DOC | ||
| GSE2240A | Comparison of atrial tissue of patients with atrial fibrillation and sinus rhythm with ventricular gene expression | 15877233 | GSE2240A_DOC | ||
| GSE2240B | Comparison of atrial tissue of patients with atrial fibrillation and sinus rhythm with ventricular gene expression | 15877233 | GSE2240B_DOC | ||
| GSE2241 | HOXA5 transcriptional targets | 15757903 | GSE2241_DOC | ||
| GSE2248 | Human Mesenchymal stem cell | 15971941 | GSE2248_DOC | ||
| GSE225 | HDMTX-17 pair | 12704389 | GSE225_DOC | ||
| GSE2251 | Anti-prolif. effect of E2 in breast cancer cells that re-exp. ERalpha is mediated by aberr. regulat. of cell cycle genes | 15821115 | GSE2251_DOC | ||
| GSE2256 | Lens Epithelial Cells and Lens Cortical Fiber Cells | 15851978 | GSE2256_DOC | ||
| GSE226 | HDMTX-18 pair | 12704389 | GSE226_DOC | ||
| GSE227 | HDMTX-19 pair | 12704389 | GSE227_DOC | ||
| GSE228 | HDMTX-2 pair | 12704389 | GSE228_DOC | ||
| GSE2280 | Prediction of lymphatic metastasis from primary squamous cell carcinoma of the oral cavity | 15558013 | GSE2280_DOC | ||
| GSE229 | HDMTX-20 pair | 12704389 | GSE229_DOC | ||
| GSE2292 | U2OS-ERa, U2OS-ERb, and U2OS-ERab cells treated with 4HT or E2 | 15802376 | GSE2292_DOC | ||
| GSE2294 | A Modular Analysis of Breast Cancer Reveals a Novel Low-Grade Molecular Signature in Estrogen Receptor-Positive Tumors | 16740749 | GSE2294_DOC | ||
| GSE2298 | hGSTA4-4 transfection in HLE B-3 experiment | 16005854 | GSE2298_DOC | ||
| GSE2299A | Egr-1 induced gene expression changes in HUVECs | 16818645 | GSE2299A_DOC | ||
| GSE2299B | Egr-1 induced gene expression changes in HUVECs | 16818645 | GSE2299B_DOC | ||
| GSE230 | HDMTX-21 pair | 12704389 | GSE230_DOC | ||
| GSE231 | HDMTX-22 pair | 12704389 | GSE231_DOC | ||
| GSE232 | HDMTX-3 pair | 12704389 | GSE232_DOC | ||
| GSE2322 | Expression changes induced by transmigration in human neutrophils | 16861384 | GSE2322_DOC | ||
| GSE2326A | Suqamous Cell Carcinoma of Head and Neck | GSE2326A_DOC | |||
| GSE2326B | Suqamous Cell Carcinoma of Head and Neck | GSE2326B_DOC | |||
| GSE2327 | siRNA mediated WTAP knockdown in HUVEC | GSE2327_DOC | |||
| GSE2328A | Application of genome-wide expression analysis to human health & disease | 15781863 | GSE2328A_DOC | ||
| GSE2328B | Application of genome-wide expression analysis to human health & disease | 15781863 | GSE2328B_DOC | ||
| GSE233 | HDMTX-4 pair | 12704389 | GSE233_DOC | ||
| GSE234 | HDMTX-5 pair | 12704389 | GSE234_DOC | ||
| GSE235 | HDMTX-6 pair | 12704389 | GSE235_DOC | ||
| GSE2350 | Normal and transformed human mature B cells | 15778709 | GSE2350_DOC | ||
| GSE2351 | chemotherapy cross-resistance and treatment response in childhood acute lymphoblastic leukemia | GSE2351_DOC | |||
| GSE236 | HDMTX-7 pair | 12704389 | GSE236_DOC | ||
| GSE237 | HDMTX-8 pair | 12704389 | GSE237_DOC | ||
| GSE238 | HDMTX-9 pair | 12704389 | GSE238_DOC | ||
| GSE239 | LDMTX_MP-1 pair | 12704389 | GSE239_DOC | ||
| GSE240 | LDMTX_MP-10 pair | 12704389 | GSE240_DOC | ||
| GSE241 | LDMTX_MP-11 pair | 12704389 | GSE241_DOC | ||
| GSE242 | LDMTX_MP-12 pair | 12704389 | GSE242_DOC | ||
| GSE2429 | Atypical Ductal Hyperplasia | 15864312 | GSE2429_DOC | ||
| GSE243 | LDMTX_MP-13 pair | 12704389 | GSE243_DOC | ||
| GSE244 | LDMTX_MP-14 pair | 12704389 | GSE244_DOC | ||
| GSE2443 | Prostate cancer - comparison of androgen-dependent and -independent microdissected primary tumor | 16203770 | GSE2443_DOC | ||
| GSE245 | LDMTX_MP-15 pair | 12704389 | GSE245_DOC | ||
| GSE246 | LDMTX_MP-16 pair | 12704389 | GSE246_DOC | ||
| GSE247 | LDMTX_MP-2 pair | 12704389 | GSE247_DOC | ||
| GSE248 | LDMTX_MP-3 pair | 12704389 | GSE248_DOC | ||
| GSE249 | LDMTX_MP-4 pair | 12704389 | GSE249_DOC | ||
| GSE250 | LDMTX_MP-5 pair | 12704389 | GSE250_DOC | ||
| GSE251 | LDMTX_MP-6 pair | 12704389 | GSE251_DOC | ||
| GSE252 | LDMTX_MP-7 pair | 12704389 | GSE252_DOC | ||
| GSE253 | LDMTX_MP-8 pair | 12704389 | GSE253_DOC | ||
| GSE254 | LDMTX_MP-9 pair | 12704389 | GSE254_DOC | ||
| GSE255 | MP-1 pair | 12704389 | GSE255_DOC | ||
| GSE2552 | Mapping Determinants of Human Gene Expression by Regional and Whole Genome Association | 16251966 | GSE2552_DOC | ||
| GSE256 | MP-10 pair | 12704389 | GSE256_DOC | ||
| GSE257 | MP-11 pair | 12704389 | GSE257_DOC | ||
| GSE258 | MP-12 pair | 12704389 | GSE258_DOC | ||
| GSE259 | MP-2 pair | 12704389 | GSE259_DOC | ||
| GSE260 | MP-3 pair | 12704389 | GSE260_DOC | ||
| GSE2603 | Subpopulations of MDA-MB-231 and Primary Breast Cancers | 16049480 | GSE2603_DOC | ||
| GSE261 | MP-4 pair | 12704389 | GSE261_DOC | ||
| GSE262 | MP-5 pair | 12704389 | GSE262_DOC | ||
| GSE263 | MP-6 pair | 12704389 | GSE263_DOC | ||
| GSE264 | MP-7 pair | 12704389 | GSE264_DOC | ||
| GSE265 | MP-8 pair | 12704389 | GSE265_DOC | ||
| GSE266 | MP-9 pair | 12704389 | GSE266_DOC | ||
| GSE267 | LDMTX_MP | 12704389 | GSE267_DOC | ||
| GSE268 | HDMTX | 12704389 | GSE268_DOC | ||
| GSE269 | HDMTX_MP | 12704389 | GSE269_DOC | ||
| GSE270 | MP | 12704389 | GSE270_DOC | ||
| GSE2724 | The effect of FH mutations on fibroid expression profile, normal myometrium vs. FH-mutant fibroids. | 16319128 | GSE2724_DOC | ||
| GSE281 | Inflammatory myopathy | 12391344 | GSE281_DOC | ||
| GSE2990 | Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis | 16478745 | GSE2990_DOC | ||
| GSE3013 | Actions of tamoxifen in the uterus and its molecular effectors in endometrial carcinogenesis. | 16355216 | GSE3013_DOC | ||
| GSE3141 | Lung Cancer Dataset | 16273092 | GSE3141_DOC | ||
| GSE3143 | Breast Cancer Dataset | 16273092 | GSE3143_DOC | ||
| GSE3156 | Breast Cancer Cell Lines | 16273092 | GSE3156_DOC | ||
| GSE3185A | Human Glioblastoma | GSE3185A_DOC | |||
| GSE3185B | Human Glioblastoma | GSE3185B_DOC | |||
| GSE3188A | Hypoxic regulation of gene expression is dominated by the HIF system and can be mimicked by DMOG | 16565084 | GSE3188A_DOC | ||
| GSE3188B | Hypoxic regulation of gene expression is dominated by the HIF system and can be mimicked by DMOG | 16565084 | GSE3188B_DOC | ||
| GSE349 | Resistant | 12907009 | GSE349_DOC | ||
| GSE3494A | An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival | 16141321 | GSE3494A_DOC | ||
| GSE3494B | An expression signature for p53 in breast cancer predicts mutation status, transcriptional effects, and patient survival | 16141321 | GSE3494B_DOC | ||
| GSE350 | Sensitive | 12907009 | GSE350_DOC | ||
| GSE3529 | Profiling of three different ER+ breast cancer cell lines grown in the presence and absence of estrogen. | 15986123 | GSE3529_DOC | ||
| GSE3542 | Profiling of MCF-7 cell lines stably overexpressing (ca)Raf-1, (ca)MEK, (ca)erbB-2, or ligand-activatable EGFR. | 16585219 | GSE3542_DOC | ||
| GSE3589 | Leukotriene D4- and Thrombin-Triggered Transcriptomes in Human Umbilical Vein Endothelial Cells | 16606835 | GSE3589_DOC | ||
| GSE360 | Macrophages and dendritic cells exposed to phylogenetically distinct parasites | 12663451 | GSE360_DOC | ||
| GSE3744 | Human breast tumor expression | 16473279 | GSE3744_DOC | ||
| GSE3834A | Profiling of ER+ BrC cells with and without estradiol in both cell cultures and xenografts | GSE3834A_DOC | |||
| GSE3834B | Profiling of ER+ BrC cells with and without estradiol in both cell cultures and xenografts | GSE3834B_DOC | |||
| GSE3893A | Gene Expression Profiling of matched Ductal Carcinomas in Situ and Invasive Breast Tumors | 16707453 | GSE3893A_DOC | ||
| GSE3893B | Gene Expression Profiling of matched Ductal Carcinomas in Situ and Invasive Breast Tumors | 16707453 | GSE3893B_DOC | ||
| GSE3894 | Heterozygous carriers of Nijmegen Breakage Syndrome Have a Distinct Gene Expression Phenotype. | 16809669 | GSE3894_DOC | ||
| GSE4006 | Estrogen effects on MCF-7 breast cancer cells co-expressing ERa and ERb | 16809442 | GSE4006_DOC | ||
| GSE4025 | Gene Expression Preferentially Regulated by Tamoxifen in Breast Cancer Cells | 16849584 | GSE4025_DOC | ||
| GSE412 | Treatment-specific changes in gene expression discriminate in vivo drug response in human leukemia cells | 12704389 | GSE412_DOC | ||
| GSE420 | Aortic stiffness | 14530203 | GSE420_DOC | ||
| GSE427 | Human Fibroblast Set: Hacia Laboratory | 12840040 | GSE427_DOC | ||
| GSE4292 | PTHrP-responsive genes in breast cancer | 16551631 | GSE4292_DOC | ||
| GSE430 | Effect of left ventricular assist device support on congestive heart failure patients | 12824457 | GSE430_DOC | ||
| GSE443 | Leprosy lesion gene expression | 12970564 | GSE443_DOC | ||
| GSE448 | WS1 response to high dose of UV-C | 12907719 | GSE448_DOC | ||
| GSE449 | WS1 response to low dose of UV-C | 12907719 | GSE449_DOC | ||
| GSE4573 | Gene expression signatures for predicting prognosis of squamous cell lung carcinomas | 16885343 | GSE4573_DOC | ||
| GSE465A | Expression profiling in the muscular dystrophies | 11121445 | GSE465A_DOC | ||
| GSE465B | Expression profiling in the muscular dystrophies | 11121445 | GSE465B_DOC | ||
| GSE465C | Expression profiling in the muscular dystrophies | 11121445 | GSE465C_DOC | ||
| GSE465D | Expression profiling in the muscular dystrophies | 11121445 | GSE465D_DOC | ||
| GSE465E | Expression profiling in the muscular dystrophies | 11121445 | GSE465E_DOC | ||
| GSE4668 | Expression data from hormone-starved MCF7/BUS cell culture | 14610279 | GSE4668_DOC | ||
| GSE468 | Expression profiling of medulloblastoma | 11544480 | GSE468_DOC | ||
| GSE4922A | Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer | GSE4922A_DOC | |||
| GSE4922B | Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer | GSE4922B_DOC | |||
| GSE493A | Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis | 11937576 | GSE493A_DOC | ||
| GSE500 | CD34+ cell analysis | 11669215 | GSE500_DOC | ||
| GSE5102 | Genomic profile of the estrogen induced neoplastic transformation of the human breast epithelial cell MCF10F | GSE5102_DOC | |||
| GSE511 | Proliferating normal human peripheral blood mononuclear cells infected with HIV type 1 RF | 11839152 | GSE511_DOC | ||
| GSE516 | TNF treated Synoviocytes | 12965196 | GSE516_DOC | ||
| GSE5327 | Breast cancer relapse free survival and lung metastasis free survival | 17420468 | GSE5327_DOC | ||
| GSE567 | Essential Thrombocythemia (ET) vs Normal (baseline) Megakaryocytes | 15271793 | GSE567_DOC | ||
| GSE574 | Idiopathic thrombocytopenic purpura (ITP) | 12937414 | GSE574_DOC | ||
| GSE5859A | Allelic Differences Account for Gene Expression Differences Among Population. | 17206142 | GSE5859A_DOC | ||
| GSE590 | USF1 haplotype comparison | 14991056 | GSE590_DOC | ||
| GSE595 | Human skeletal muscle | 14625377 | GSE595_DOC | ||
| GSE609A | SCID vs Normal Thymocyte Comparisons | 14602880 | GSE609A_DOC | ||
| GSE609B | SCID vs Normal Thymocyte Comparisons | 14602880 | GSE609B_DOC | ||
| GSE620A | Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line | 14583596 | GSE620A_DOC | ||
| GSE620B | Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line | 14583596 | GSE620B_DOC | ||
| GSE6253A | A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253A_DOC | ||
| GSE6253B | A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253B_DOC | ||
| GSE6253C | A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer | 17194181 | GSE6253C_DOC | ||
| GSE635 | Identification of novel genomic determinants of cellular drug resistance in acute lymphoblastic leukemia. | 15295046 | GSE635_DOC | ||
| GSE6429 | HGPC, in monolayer, 0.5 vs. 20% serum, complete | GSE6429_DOC | |||
| GSE643 | ASP sensitive all ALL | 15295046 | GSE643_DOC | ||
| GSE6434 | Docetaxel treatment of sensitve and resistant patients | GSE6434_DOC | |||
| GSE645 | ASP resistant all ALL | 15295046 | GSE645_DOC | ||
| GSE646 | PRED sensitive all ALL | 15295046 | GSE646_DOC | ||
| GSE647 | PRED resistant all ALL | 15295046 | GSE647_DOC | ||
| GSE648 | VCR sensitive all ALL | 15295046 | GSE648_DOC | ||
| GSE649 | VCR resistant all ALL | 15295046 | GSE649_DOC | ||
| GSE64A | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64A_DOC | ||
| GSE64B | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64B_DOC | ||
| GSE64C | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64C_DOC | ||
| GSE64D | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64D_DOC | ||
| GSE64E | Insulin sensitive muscle sample pool 1 | 12436343 | GSE64E_DOC | ||
| GSE650 | DNR sensitive all ALL | 15295046 | GSE650_DOC | ||
| GSE651 | DNR resistant all ALL | 15295046 | GSE651_DOC | ||
| GSE653 | ASP sensitive B-ALL | 15295046 | GSE653_DOC | ||
| GSE6532A | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532A_DOC | ||
| GSE6532B | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532B_DOC | ||
| GSE6532C | Definition of clinically distinct molecular subtypes in estrogen receptor positive breast carcinomas using genomic grade | 17401012 | GSE6532C_DOC | ||
| GSE654 | ASP resistant B-ALL | 15295046 | GSE654_DOC | ||
| GSE655 | PRED sensitive B-ALL | 15295046 | GSE655_DOC | ||
| GSE656 | PRED resistant B-ALL | 15295046 | GSE656_DOC | ||
| GSE657 | VCR sensitive B-ALL | 15295046 | GSE657_DOC | ||
| GSE658 | VCR resistant B-ALL | 15295046 | GSE658_DOC | ||
| GSE659 | DNR sensitive B-ALL | 15295046 | GSE659_DOC | ||
| GSE65A | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65A_DOC | ||
| GSE65B | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65B_DOC | ||
| GSE65C | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65C_DOC | ||
| GSE65D | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65D_DOC | ||
| GSE65E | Insulin sensitive muscle sample pool 2 | 12436343 | GSE65E_DOC | ||
| GSE660 | DNR resistant B-ALL | 15295046 | GSE660_DOC | ||
| GSE6604A | Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604A_DOC | ||
| GSE6604B | Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604B_DOC | ||
| GSE6604C | Expression data from Normal Prostate Tissue free of any pathological alteration | 17430594 | GSE6604C_DOC | ||
| GSE6605A | Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605A_DOC | ||
| GSE6605B | Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605B_DOC | ||
| GSE6605C | Expression data from Metastatic Prostate Tumor | 17430594 | GSE6605C_DOC | ||
| GSE6606A | Expression data from Primary Prostate Tumor | 17430594 | GSE6606A_DOC | ||
| GSE6606B | Expression data from Primary Prostate Tumor | 17430594 | GSE6606B_DOC | ||
| GSE6606C | Expression data from Primary Prostate Tumor | 17430594 | GSE6606C_DOC | ||
| GSE6608A | Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608A_DOC | ||
| GSE6608B | Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608B_DOC | ||
| GSE6608C | Expression data from Normal Prostate Tissue Adjacent to Tumor | 17430594 | GSE6608C_DOC | ||
| GSE66A | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66A_DOC | ||
| GSE66B | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66B_DOC | ||
| GSE66C | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66C_DOC | ||
| GSE66D | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66D_DOC | ||
| GSE66E | Insulin sensitive muscle sample pool 3 | 12436343 | GSE66E_DOC | ||
| GSE675 | Time course analysis of response to HCMV infection | 11711622 | GSE675_DOC | ||
| GSE67A | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67A_DOC | ||
| GSE67B | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67B_DOC | ||
| GSE67C | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67C_DOC | ||
| GSE67D | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67D_DOC | ||
| GSE67E | Insulin sensitive muscle sample pool 4 | 12436343 | GSE67E_DOC | ||
| GSE685 | DACH1 inhibits TGF-beta signaling through binding Smad4 | 14525983 | GSE685_DOC | ||
| GSE68A | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68A_DOC | ||
| GSE68B | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68B_DOC | ||
| GSE68C | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68C_DOC | ||
| GSE68D | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68D_DOC | ||
| GSE68E | Insulin sensitive muscle sample pool 5 | 12436343 | GSE68E_DOC | ||
| GSE6919A | Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919A_DOC | ||
| GSE6919B | Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919B_DOC | ||
| GSE6919C | Expression Data from Normal and Prostate Tumor Tissues | 17430594 | GSE6919C_DOC | ||
| GSE69A | Insulin resistant muscle sample pool 1 | 12436343 | GSE69A_DOC | ||
| GSE69B | Insulin resistant muscle sample pool 1 | 12436343 | GSE69B_DOC | ||
| GSE69C | Insulin resistant muscle sample pool 1 | 12436343 | GSE69C_DOC | ||
| GSE69D | Insulin resistant muscle sample pool 1 | 12436343 | GSE69D_DOC | ||
| GSE69E | Insulin resistant muscle sample pool 1 | 12436343 | GSE69E_DOC | ||
| GSE701 | Transcriptional response of lymphoblastoid cells to ionizing radiation | 12915489 | GSE701_DOC | ||
| GSE703 | Blood pulmonary arterial hypertension | 15215156 | GSE703_DOC | ||
| GSE70A | Insulin resistant muscle sample pool 2 | 12436343 | GSE70A_DOC | ||
| GSE70B | Insulin resistant muscle sample pool 2 | 12436343 | GSE70B_DOC | ||
| GSE70C | Insulin resistant muscle sample pool 2 | 12436343 | GSE70C_DOC | ||
| GSE70D | Insulin resistant muscle sample pool 2 | 12436343 | GSE70D_DOC | ||
| GSE70E | Insulin resistant muscle sample pool 2 | 12436343 | GSE70E_DOC | ||
| GSE713 | UV radiation-induced DNA damage | 12907719 | GSE713_DOC | ||
| GSE71A | Insulin resistant muscle sample pool 3 | 12436343 | GSE71A_DOC | ||
| GSE71B | Insulin resistant muscle sample pool 3 | 12436343 | GSE71B_DOC | ||
| GSE71C | Insulin resistant muscle sample pool 3 | 12436343 | GSE71C_DOC | ||
| GSE71D | Insulin resistant muscle sample pool 3 | 12436343 | GSE71D_DOC | ||
| GSE71E | Insulin resistant muscle sample pool 3 | 12436343 | GSE71E_DOC | ||
| GSE72A | Insulin resistant muscle sample pool 4 | 12436343 | GSE72A_DOC | ||
| GSE72B | Insulin resistant muscle sample pool 4 | 12436343 | GSE72B_DOC | ||
| GSE72C | Insulin resistant muscle sample pool 4 | 12436343 | GSE72C_DOC | ||
| GSE72D | Insulin resistant muscle sample pool 4 | 12436343 | GSE72D_DOC | ||
| GSE72E | Insulin resistant muscle sample pool 4 | 12436343 | GSE72E_DOC | ||
| GSE7307 | Human body index - transcriptional profiling | GSE7307_DOC | |||
| GSE7390 | Strong Time Dependence of the 76-Gene Prognostic Signature | 17545524 | GSE7390_DOC | ||
| GSE73A | Insulin resistant muscle sample pool 5 | 12436343 | GSE73A_DOC | ||
| GSE73B | Insulin resistant muscle sample pool 5 | 12436343 | GSE73B_DOC | ||
| GSE73C | Insulin resistant muscle sample pool 5 | 12436343 | GSE73C_DOC | ||
| GSE73D | Insulin resistant muscle sample pool 5 | 12436343 | GSE73D_DOC | ||
| GSE73E | Insulin resistant muscle sample pool 5 | 12436343 | GSE73E_DOC | ||
| GSE753 | MRI-no-lytic-lesion | 14695408 | GSE753_DOC | ||
| GSE754 | MRI-lytic-lesion | 14695408 | GSE754_DOC | ||
| GSE755 | MRI lytic and no lytic lesions | 14695408 | GSE755_DOC | ||
| GSE758 | Gene expression in human optic nerve head (ONH) astrocytes | 14747662 | GSE758_DOC | ||
| GSE764 | Comparison of Gene Expression in Uterine Smooth Muscle Tumors | GSE764_DOC | |||
| GSE781A | Normal and Renal Cell Carcinoma Kidney Tissue, Human | 14641932 | GSE781A_DOC | ||
| GSE781B | Normal and Renal Cell Carcinoma Kidney Tissue, Human | 14641932 | GSE781B_DOC | ||
| GSE803A | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803A_DOC | ||
| GSE803B | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803B_DOC | ||
| GSE803C | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803C_DOC | ||
| GSE803D | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803D_DOC | ||
| GSE803E | GeneNote-Gene Normal tissue Expression | 15388519 | GSE803E_DOC | ||
| GSE8218 | Gene expression data from prostate cancer samples | GSE8218_DOC | |||
| GSE846 | Conversion | 14702632 | GSE846_DOC | ||
| GSE847 | HS to HR progression | 14702632 | GSE847_DOC | ||
| GSE848 | E2 and SERM Treatment of MCF-7 Breast Cancer Cells | 14973112 | GSE848_DOC | ||
| GSE88 | Bladder tumour recurrence prediction | 12469123 | GSE88_DOC | ||
| GSE89 | Bladder tumour stage classification | 12469123 | GSE89_DOC | ||
| GSE923 | Pseudomonas aeruginosa infection of Calu-3 human lung epithelial cells | 15494517 | GSE923_DOC | ||
| GSE935 | NIH/NIAID Chronic Granulomatous Disease Neutrophils | 14688376 | GSE935_DOC | ||
| GSE96 | Large-scale analysis of the human transcriptome | 11904358 | GSE96_DOC | ||
| GSE973 | IL-1 stimulation of HUVEC | 15130917 | GSE973_DOC | ||
| GSE974 | Left ventricular apex samples | 14872006 | GSE974_DOC | ||
| GSE976 | Gene Expression-Based High Throughput Screening: APL Treatment with Candidate Compounds | 14770183 | GSE976_DOC | ||
| GSE981 | Endothelin-1 (ET-1) treated lung fibroblasts | GSE981_DOC | |||
| GSE982 | Gene Expression-Based High Throughput Screening: HL-60 Cell Treatment with Candidate Compounds | 14770183 | GSE982_DOC | ||
| GSE983 | Gene Expression-Based High Throughput Screening: Primary Patient AML Blasts, Normal Neutrophils, and Normal Monocytes | 14770183 | GSE983_DOC | ||
| GSE985 | Gene Expression-Based High Throughput Screening: HL-60 Cells Treated with ATRA and PMA | 14770183 | GSE985_DOC | ||
| GSE995A | Differentiation of acute myeloid leukemia cells | 14770183 | GSE995A_DOC | ||
| GSE995B | Differentiation of acute myeloid leukemia cells | 14770183 | GSE995B_DOC | ||
| GSE997 | Essential Thrombocythemia megakaryocytes versus normal megakaryocytes | 15271793 | GSE997_DOC | ||
| GSE998 | Amino Acid Conjugated Surfaces and Controls 6 Hours | GSE998_DOC | |||
| GSE999 | Amino Acid Conjugated Surfaces and Controls 32 Hours | GSE999_DOC | |||
| BASIC 33 | C0001 | Classification of human astrocytic gliomas | 14583454 | C0001_DOC | |
| GSE1361 | Concurrent Versus Individual Binding of HuR and AUF1 to Common Labile Target mRNAs | 15257295 | GSE1361_DOC | ||
| GSE137 | Natural variation in human gene expression assessed in lymphoblastoid cells | 12567189 | GSE137_DOC | ||
| GSE1433 | TIAR represses c-Myc biosynthesis following ultraviolet light irradiation | 16537914 | GSE1433_DOC | ||
| GSE1434 | HaCaT +GLI1/2 24/72h | 16434164 | GSE1434_DOC | ||
| GSE1440 | TIAR represses c-Myc biosynthesis following ultraviolet light irradiation-2 | GSE1440_DOC | |||
| GSE1510 | Human UniGene Set RZPD 1 - Zipf's Normalization | GSE1510_DOC | |||
| GSE1511 | Gene expression profile of CD56dimCD16+, CD56brightCD16- and activated CD56+CD16+ human NK subsets | 15557145 | GSE1511_DOC | ||
| GSE1710 | Expression profiling in inflammatory bowel disease | 16107186 | GSE1710_DOC | ||
| GSE1748 | VI-28 treatment induced alteration of gene expression in human lymphocytes | GSE1748_DOC | |||
| GSE1767 | Human blood expression for Huntington's disease versus control, Codelink | 16043692 | GSE1767_DOC | ||
| GSE1836 | Comparison of native versus cultured RPE cells | 16234463 | GSE1836_DOC | ||
| GSE2046 | Hep3B time-course | GSE2046_DOC | |||
| GSE2052 | IPF versus Control | 16128620 | GSE2052_DOC | ||
| GSE2053 | RAvs.ND | GSE2053_DOC | |||
| GSE2075 | Rosetta_miRNA_transfection_experiment | 15685193 | GSE2075_DOC | ||
| GSE2097 | Epigenetic treatment of cervical carcinoma cell lines | 16434596 | GSE2097_DOC | ||
| GSE2143 | Human coronary artery study | 15942018 | GSE2143_DOC | ||
| GSE2177 | Trascriptional profiling of angiogenic inhibitors | 12499246 | GSE2177_DOC | ||
| GSE2182 | Drug treatment comparison | GSE2182_DOC | |||
| GSE2243 | RIZ1 repression is associated with insulin-like growth factor-1 signaling activation in chronic myeloid leukemia... | 16953217 | GSE2243_DOC | ||
| GSE2845 | Human breast tumor | GSE2845_DOC | |||
| GSE3155A | Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | GSE3155A_DOC | |||
| GSE3155B | Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | GSE3155B_DOC | |||
| GSE3155C | Gene expression profiling of the 20 human early breast carcinomas by three miaroarray platforms | GSE3155C_DOC | |||
| GSE3570 | cDNA array of the new human breast cancer cell line EM-G3 derived from breast cancer progenitor cells | GSE3570_DOC | |||
| GSE4056 | Expression profiling of human primary breast cancer tissue before treatment with gemcitabine, epirubicine and docetaxel | 16622258 | GSE4056_DOC | ||
| GSE465F | Expression profiling in the muscular dystrophies | 11121445 | GSE465F_DOC | ||
| GSE4716A | Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 15064725 | GSE4716A_DOC | ||
| GSE4716B | Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients | 15064725 | GSE4716B_DOC | ||
| GSE4882 | A Gene Expression Signature to Predict Metastasis and Survival in Non-small Cell Lung Cancer | 17202451 | GSE4882_DOC | ||
| GSE493B | Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis | 11937576 | GSE493B_DOC | ||
| GSE6752 | CodeLink Expression Data from primary prostate tumor and prostate tumor metastases | 17430594 | GSE6752_DOC | ||
| COUNTS 23 | GSE10 | eye-SAGE | 11756676 | GSE10_DOC | |
| GSE14 | CGAP SAGE | 11257097 | GSE14_DOC | ||
| GSE1439 | Differentiation of cultured THP-1 cells | GSE1439_DOC | |||
| GSE17 | Young and old muscle comparison | 10904065 | GSE17_DOC | ||
| GSE1747 | Human 32 MPSS samples | GSE1747_DOC | |||
| GSE1902 | Cancer Genome Anatomy Project (Human: longSAGE) | GSE1902_DOC | |||
| GSE2017 | Genomic alterations in primary hyperaldosteronism | 16204365 | GSE2017_DOC | ||
| GSE2055 | Human Adrenal Cortex affected by Primary Pigmented Nodular Adrenocortical Disease | GSE2055_DOC | |||
| GSE2056 | PBECs stimulated with pro-inflammatory cytokines and P. aeruginosa | 15701729 | GSE2056_DOC | ||
| GSE2346 | The pattern of gene expression in human CD34(+) stem/progenitor cells | 11717454 | GSE2346_DOC | ||
| GSE278 | Pancreas and islet gene expression | GSE278_DOC | |||
| GSE31 | SAGE_HumanEpidermis | 11772949 | GSE31_DOC | ||
| GSE41 | Effects of estrogen | 11085516 | GSE41_DOC | ||
| GSE505 | Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy | 12556388 | GSE505_DOC | ||
| GSE506 | Fibroblast cells immediate-early after human cytomegalovirus infection | 11124023 | GSE506_DOC | ||
| GSE507 | Novel estrogen and tamoxifen induced genes | 11850811 | GSE507_DOC | ||
| GSE508 | Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation | 12036942 | GSE508_DOC | ||
| GSE514 | AIDS-related Kaposi's sarcoma | 12697073 | GSE514_DOC | ||
| GSE545 | SAGE Hiroshima gastric cancer tissue | 15059891 | GSE545_DOC | ||
| GSE608 | Human embryonic stem cells | 14688391 | GSE608_DOC | ||
| GSE694 | SADE analysis of microdissected kidney | 14595018 | GSE694_DOC | ||
| GSE953 | Effect of TERT and ATM on Gene Expression Profiles in Human Fibroblasts | 14978791 | GSE953_DOC | ||
| HSEST | Tissue break-down of ESTs derived from Unigene clusters | 8849440 | HSEST_DOC | ||
| CUSTOM | GSE1133B | tissue-specific pattern of mRNA expression | 15075390 | GSE1133B_DOC | |
| DUAL 105 | GSE1 | NHGRI_Melanoma_class | 10952317 | GSE1_DOC | |
| GSE1030A | H295RAII3h | 15375197 | GSE1030A_DOC | ||
| GSE1030B | H295RAII3h | 15375197 | GSE1030B_DOC | ||
| GSE1037 | Lung cancer | GSE1037_DOC | |||
| GSE1039 | Differential Gene Expression by Memory T Helper Cells Bearing the Gut-Homing Receptor Integrin α4β7 | 15236665 | GSE1039_DOC | ||
| GSE1041 | Responses of HUVEC to Hypoxia and Reoxygenation | GSE1041_DOC | |||
| GSE105 | Lipopolysaccharide-stimulated neutrophils | 12495940 | GSE105_DOC | ||
| GSE1054 | EP300 knock-out image segmentation | 15028803 | GSE1054_DOC | ||
| GSE1057 | Human lupus and normal CD4 T cells response to anti-CD3 treatment | GSE1057_DOC | |||
| GSE112A | Distinctive gene expression patterns in gastrointestinal stromal tumors identified with cDNA arrays | GSE112A_DOC | |||
| GSE112B | Distinctive gene expression patterns in gastrointestinal stromal tumors identified with cDNA arrays | GSE112B_DOC | |||
| GSE1276 | Effect of cigarette smoke on normal human bronchial epithelial cells, and S9 toxicity | 15326394 | GSE1276_DOC | ||
| GSE1279 | Tubular carcinoma and adenoma | 15800983 | GSE1279_DOC | ||
| GSE1288 | Cytokine Stimulated Vs Unstimulated | GSE1288_DOC | |||
| GSE1291 | Adenovirus vs Mock Infection | GSE1291_DOC | |||
| GSE1292 | HSP27 3A vs WT | GSE1292_DOC | |||
| GSE1319 | Immunohistochemical and Clinical Characterization of the Basal-like Subtype | 15328174 | GSE1319_DOC | ||
| GSE1366 | Total-body irradiation dose response | 15374940 | GSE1366_DOC | ||
| GSE1369 | Sham-irradiated vs pool of sham-irradiated keratinocytes | 15691830 | GSE1369_DOC | ||
| GSE1370 | Irradiated vs sham irradiated keratynocytes | 15691830 | GSE1370_DOC | ||
| GSE1378 | breast cancer / tamoxifen monotherapy (microdissected tumor biopsies) | 15193263 | GSE1378_DOC | ||
| GSE1379 | breast cancer / tamoxifen monotherapy (whole tissue tumor biopsies) | 15193263 | GSE1379_DOC | ||
| GSE1406 | vGPCR and lytic KSHV time course in TIME cells | 15289507 | GSE1406_DOC | ||
| GSE1484 | PDGF stimulation kinetics | 15213220 | GSE1484_DOC | ||
| GSE1486 | Steroids_Effect_on_HUVEC_Response_to_LPS_or_Cytokines | GSE1486_DOC | |||
| GSE1487 | DU 145 EMETINE TIME COURSE | 15300251 | GSE1487_DOC | ||
| GSE1488 | LNCaP EMETINE TIME COURSE | 15300251 | GSE1488_DOC | ||
| GSE1489 | PC3 EMETINE TIME COURSE | 15300251 | GSE1489_DOC | ||
| GSE1490 | GM00156 EMETINE TIME COURSE | 15300251 | GSE1490_DOC | ||
| GSE1545 | Human podocyte differentiation | GSE1545_DOC | |||
| GSE1549 | Intestinal cells infected with Vibrio cholerae | 15213169 | GSE1549_DOC | ||
| GSE1645 | TAcKLE - Transcriptome Amplification and cDNA Labeling for Expression analysis | 15718295 | GSE1645_DOC | ||
| GSE1647 | Prediction of toxicant-specific gene expression signatures following chemotherapeutic treatment of breast cell lines | 15598611 | GSE1647_DOC | ||
| GSE1694 | Promyelocytic cells response to Anaplasma phagocytophilum infection | 15760455 | GSE1694_DOC | ||
| GSE1704 | Epithelial cells in contact with bacterial supernatant | 15598879 | GSE1704_DOC | ||
| GSE1705 | EGFR inhibitors block basal-like breast cancer growth | GSE1705_DOC | |||
| GSE1715 | mCGH of cervical cancer | GSE1715_DOC | |||
| GSE1718 | Preâand Post-training arrays/Insulin sensitivity response | 15687108 | GSE1718_DOC | ||
| GSE1726 | Rosetta_Merck_CEPH_Study | 15514893 | GSE1726_DOC | ||
| GSE1755 | Array-based comparative genomic hybridization for distinguishing paraffin-embedded Spitz nevi and melanomas | 15163005 | GSE1755_DOC | ||
| GSE1818 | Testicular germ cell tumors and their histological subgroups | 15994931 | GSE1818_DOC | ||
| GSE1827 | Waldman Bladder tumors | GSE1827_DOC | |||
| GSE1864 | A genomic view of estrogen actions in human breast cancer cells | 15171711 | GSE1864_DOC | ||
| GSE1898 | Human Hepatocellular Carcinoma study | 15565109 | GSE1898_DOC | ||
| GSE1900 | Immortalization of normal human cells | 15942647 | GSE1900_DOC | ||
| GSE1991 | Array-CGH in human glial brain tumors | 15899798 | GSE1991_DOC | ||
| GSE1992 | A New Breast Tumor Intrinsic Gene List Identifies Novel Characteristics that are Conserved Across Microarray Platforms | 16643655 | GSE1992_DOC | ||
| GSE2003 | NCI cDNA microarray-human 60 cell lines | 10700174 | GSE2003_DOC | ||
| GSE2014 | Molecular classification of failing hearts from coronary and myopathic patients | GSE2014_DOC | |||
| GSE2020 | Differential Gene Up-regulation by HIF-1a and HIF-2a in HEK293T. | 15833863 | GSE2020_DOC | ||
| GSE2035 | Hearts_DD_Screening | GSE2035_DOC | |||
| GSE2047 | folic acid | GSE2047_DOC | |||
| GSE2048 | Breast Cancer: Invasive Ductal Carcinoma | GSE2048_DOC | |||
| GSE2051 | Hearts_tissue_expression_profile | GSE2051_DOC | |||
| GSE2058 | Identification of drug associated genes in ovarian cancer by RNA profiling | GSE2058_DOC | |||
| GSE2061 | Hearts_tissue_expression_profile_2 | GSE2061_DOC | |||
| GSE2062 | Hearts_tissue_expression_profile_3 | GSE2062_DOC | |||
| GSE2155 | Microarray Analysis of Gene Expression in Human Normal and Breast Cancer Cells | 15659406 | GSE2155_DOC | ||
| GSE2179 | Expression profiling of secreted and cell surface genes of 5 transformed cell lines and derivative xenograft tumors | GSE2179_DOC | |||
| GSE2193 | Normal_human_tissues | 15774023 | GSE2193_DOC | ||
| GSE2194 | Normal_human_tissues_genomic_controls | GSE2194_DOC | |||
| GSE2221 | Drug resistance in glioblastoma | 16365179 | GSE2221_DOC | ||
| GSE2223 | Gene expression profiling in human glial brain tumors | 16204036 | GSE2223_DOC | ||
| GSE2283A | Primary human neuroblastoma | 15837623 | GSE2283A_DOC | ||
| GSE2283B | Primary human neuroblastoma | 15837623 | GSE2283B_DOC | ||
| GSE2345 | Human TK6 cells treated with BPDE or N-OH-AABP yielding 5%, 15% and 40% of toxicity | GSE2345_DOC | |||
| GSE2584 | Gene expression patterns induced by 5-Fluorouracil in breast cancer cell lines | 16557594 | GSE2584_DOC | ||
| GSE2607 | Biological Classification of Breast Cancer by Real-Time Quantitative RTPCR: Comparisons to Microarray and Histopathology | 16626501 | GSE2607_DOC | ||
| GSE2740 | Estrogen-regulated genes predict survival in estrogen receptor and/or progesterone receptor-positive breast cancers | 16505416 | GSE2740_DOC | ||
| GSE2741 | Breast Tumor's study | 16230372 | GSE2741_DOC | ||
| GSE2987 | RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer | 11533059 | GSE2987_DOC | ||
| GSE3165A | Identification of conserved gene expression features across human and murine mammary tumors murine mammary tumors | GSE3165A_DOC | |||
| GSE3178 | Gene expression patterns associated with p53 status in breast cancer | 17150101 | GSE3178_DOC | ||
| GSE3192 | Partially degraded RNA from bladder washing is a suitable sample for studying gene expression profiles of bladder cancer | GSE3192_DOC | |||
| GSE3193 | Breast Tumor Clinical Implications | 11553815 | GSE3193_DOC | ||
| GSE3211 | Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia | 11733578 | GSE3211_DOC | ||
| GSE3281 | Breast Cancer aCGH | 12297621 | GSE3281_DOC | ||
| GSE3521 | Analysis of breast tumors and metastases identify a molecular signature of the Warburg effect and fibroblast patterns | GSE3521_DOC | |||
| GSE3762A | Effects of Estrogen and Tamoxifen on Ishikawa cells after 24h and 48h | GSE3762A_DOC | |||
| GSE3762B | Effects of Estrogen and Tamoxifen on Ishikawa cells after 24h and 48h | GSE3762B_DOC | |||
| GSE3901 | Response of quiescent human fibroblasts to different growth factors and serum | GSE3901_DOC | |||
| GSE3933 | Prostate Cancer | 14711987 | GSE3933_DOC | ||
| GSE4027 | Prostate cancer cell line LNCaP treated for 2, 4, 6, 8 h with the synthetic androgen R1881 (1nM) | 16707422 | GSE4027_DOC | ||
| GSE425 | Acute myeloid leukemia study | 15084693 | GSE425_DOC | ||
| GSE4268 | Breast and ovarian carcinoma | 12960427 | GSE4268_DOC | ||
| GSE4335 | Norway/Stanford Breast Tumors | 12829800 | GSE4335_DOC | ||
| GSE4382 | Repeated observation of breast tumor subtypes in independent gene expression data sets | 12829800 | GSE4382_DOC | ||
| GSE53 | Human mammary epithelium and breast cancer | 10430922 | GSE53_DOC | ||
| GSE55 | Serum stimulation of fibroblasts experiment set | 9872747 | GSE55_DOC | ||
| GSE56 | Serum stimulation of fibroblasts with cycloheximide | 9872747 | GSE56_DOC | ||
| GSE57 | Serum stimulation of fibroblasts controls | 9872747 | GSE57_DOC | ||
| GSE58 | Serum stimulation of fibroblasts | 9872747 | GSE58_DOC | ||
| GSE5803 | gene differentially expressed in androgen independent prostate cancer | GSE5803_DOC | |||
| GSE5828 | Gene expression profiling classifies lung squamous cell carcinomas with N1 positive lymph nodes | 17601969 | GSE5828_DOC | ||
| GSE5843 | Expression profiling defines a recurrence signature in lung adenocarcinoma | 17082175 | GSE5843_DOC | ||
| GSE5859B | Allelic Differences Account for Gene Expression Differences Among Population. | 17206142 | GSE5859B_DOC | ||
| GSE60 | Diffuse large B-cell lymphoma | 10676951 | GSE60_DOC | ||
| GSE61 | Molecular portraits of human breast tumors | 10963602 | GSE61_DOC | ||
| GSE6128 | EGFR signaling varies with breast tumor subtype | 17663798 | GSE6128_DOC | ||
| GSE6130 | Agreement in Breast Cancer Classification between Microarray and qRT-PCR from Fresh-Frozen and Formalin-Fixed Tissues | GSE6130_DOC | |||
| GSE6131 | Role of E2F3 expression in human bladder and prostate cancer cells | 16909110 | GSE6131_DOC | ||
| GSE6250 | Distinctive gene expression of prostatic stromal cells cultured from diseased versus normal tissues | 17044071 | GSE6250_DOC | ||
| GSE763 | Cell-type specific responses to chemotherapeutics in breast cancer | 15205334 | GSE763_DOC | ||
| R0001 | Comparison and classification of breast cancers | 11823860 | R0001_DOC | ||
| R0002 | Survival in breast cancer. | 12490681 | R0002_DOC | ||
| Mouse 326 | AFFY 180 | GSE1008 | Extraocular muscle, comparison of wild type and mdx mice, 14 to 112 Days (Porter lab) | 12874102 | GSE1008_DOC |
| GSE1011 | Chronic Rosiglitazone Mouse Aorta | 15054141 | GSE1011_DOC | ||
| GSE1018 | Leg muscle mdx and control | GSE1018_DOC | |||
| GSE1025 | Hindlimb muscle, comparison of wild type and mdx mice, 7 to 112 Day (Porter lab) | 12874102 | GSE1025_DOC | ||
| GSE1026 | Diaphram, comparison of wild type and mdx mice, 7 to 112 Days (Porter lab) | 14681298 | GSE1026_DOC | ||
| GSE1049A | Cell Culture A and B chips EOM | 16291736 | GSE1049A_DOC | ||
| GSE1049B | Cell Culture A and B chips EOM | 16291736 | GSE1049B_DOC | ||
| GSE1050 | Difference in skeletal muscle function in Males vs Females; Role of Estrogen Receptor Beta | 15280152 | GSE1050_DOC | ||
| GSE1052A | Cell Culture A and B chips leg | 16291736 | GSE1052A_DOC | ||
| GSE1052B | Cell Culture A and B chips leg | 16291736 | GSE1052B_DOC | ||
| GSE106 | OVX/P4/UTX 129/SvImJ WT A | 12554760 | GSE106_DOC | ||
| GSE1062 | Extraocular, masticatory, and hindlimb muscles, comparison of putative muscle allotypes (Porter lab) | 11572940 | GSE1062_DOC | ||
| GSE107 | OVX/P4/UTX 129/SvImJ WT B | 12554760 | GSE107_DOC | ||
| GSE108 | OVX/P4/6h/UTX 129 WT vs. Hoxa-10-/- | 12554760 | GSE108_DOC | ||
| GSE1085 | Profiling of aggressive vs benign pancreatic infiltrates in the BDC2.5 Tg model of Type I diabetes | 15141080 | GSE1085_DOC | ||
| GSE1086 | Dwarf Ad libitum | GSE1086_DOC | |||
| GSE1087 | Dwarf Calorie Restricted | 15039484 | GSE1087_DOC | ||
| GSE1088 | Normal Ad Libitum | 15039484 | GSE1088_DOC | ||
| GSE1089 | Normal Calorie Restricted | 15039484 | GSE1089_DOC | ||
| GSE109 | OVX/oil/6h/UTX 129 WT vs. Hoxa-10-/- | 12554760 | GSE109_DOC | ||
| GSE1092 | SJL, Balb: Leg and Eye, 10/12 months | GSE1092_DOC | |||
| GSE1093 | caloric restriction | 15039484 | GSE1093_DOC | ||
| GSE1096 | Hair follicle stem cell gene profile | 15024388 | GSE1096_DOC | ||
| GSE1108 | Antisense IL-10 treatment in Malignant Murine B-1 Cells | GSE1108_DOC | |||
| GSE1112 | RTOC thymocytes | 15133507 | GSE1112_DOC | ||
| GSE1123 | C3H10T1/2 Adipogenesis: Effects of EGF and TCDD | GSE1123_DOC | |||
| GSE1131 | Osteoblast differentiation experiment: BMP-2 induced osteogenesis in mouse MC3T3 cell line | 15178686 | GSE1131_DOC | ||
| GSE1134 | Na,K-ATPase alpha 1 het. heart | GSE1134_DOC | |||
| GSE1143 | Insulin-like growth factor 1 (IGF1) heart study | 14597618 | GSE1143_DOC | ||
| GSE1148 | Sex Specific Transciption in Mouse Tissues | GSE1148_DOC | |||
| GSE117 | P7 wildtype | GSE117_DOC | |||
| GSE118 | P10 wildtype | GSE118_DOC | |||
| GSE119 | P14 wildtype | GSE119_DOC | |||
| GSE120 | P18 wildtype | GSE120_DOC | |||
| GSE122 | P21 wildtype | GSE122_DOC | |||
| GSE123 | P7 knockout | GSE123_DOC | |||
| GSE124 | P10 knockout | GSE124_DOC | |||
| GSE125 | P14 knockout | GSE125_DOC | |||
| GSE126 | P18 knockout | GSE126_DOC | |||
| GSE127 | P21 knockout | GSE127_DOC | |||
| GSE128 | Rp1 knockout mice retinal development | 16126734 | GSE128_DOC | ||
| GSE1281 | Expression profile of genes in normal and Down syndrome mouse brains MGU74A | 15138197 | GSE1281_DOC | ||
| GSE1282 | Expression profile of genes in normal and Down syndrome mouse brains MGU74B | 15138197 | GSE1282_DOC | ||
| GSE1283 | KPAW and wild type eyes | GSE1283_DOC | |||
| GSE1294A | Expression profile of genes in normal and Down syndrome mouse brains | 15138197 | GSE1294A_DOC | ||
| GSE1294B | Expression profile of genes in normal and Down syndrome mouse brains | 15138197 | GSE1294B_DOC | ||
| GSE1301A | PGA Murine IL-13 Asthma | GSE1301A_DOC | |||
| GSE1301B | PGA Murine IL-13 Asthma | GSE1301B_DOC | |||
| GSE1303 | PGA Murine Lung Estrogen | GSE1303_DOC | |||
| GSE1308 | Effects of ethanol on poly IC gene induction | 15294990 | GSE1308_DOC | ||
| GSE1321 | Hypoxic response in wild type and HIF-1alpha null hepatoctyes | GSE1321_DOC | |||
| GSE135 | Erythroid Progenitor Cell Gene Expression Profiles | GSE135_DOC | |||
| GSE1358A | Embryonic Testis Developmental Time Course | 15496517 | GSE1358A_DOC | ||
| GSE1358B | Embryonic Testis Developmental Time Course | 15496517 | GSE1358B_DOC | ||
| GSE1358C | Embryonic Testis Developmental Time Course | 15496517 | GSE1358C_DOC | ||
| GSE1359A | Embryonic Ovary Developmental Time Course | 15496517 | GSE1359A_DOC | ||
| GSE1359B | Embryonic Ovary Developmental Time Course | 15496517 | GSE1359B_DOC | ||
| GSE1359C | Embryonic Ovary Developmental Time Course | 15496517 | GSE1359C_DOC | ||
| GSE1363 | Gene expression in T1alpha null mutant lungs compared to wild type at dpc 18.5 and term | GSE1363_DOC | |||
| GSE1375 | PS cDKO / Control, 6 months | 15345711 | GSE1375_DOC | ||
| GSE1381 | Snell Dwarf Response to 3-NPA | GSE1381_DOC | |||
| GSE1382 | IL10-/-DC + 0,SEA,LPS,SEA/LPS 6H | 15585871 | GSE1382_DOC | ||
| GSE1391 | Preimplantation mouse embryo development U74Av2 | 15282163 | GSE1391_DOC | ||
| GSE1392 | Comparison of conventional and germ-free gastrointestinal tract | 15226484 | GSE1392_DOC | ||
| GSE1399A | Zfp145 spermatogonia | 15156143 | GSE1399A_DOC | ||
| GSE1399B | Zfp145 spermatogonia | 15156143 | GSE1399B_DOC | ||
| GSE1399C | Zfp145 spermatogonia | 15156143 | GSE1399C_DOC | ||
| GSE13A | Murine bone marrow B cell precursors | 11779835 | GSE13A_DOC | ||
| GSE13B | Murine bone marrow B cell precursors | 11779835 | GSE13B_DOC | ||
| GSE1419 | Pancreatic T regulatory vs. T effector cells | 15184501 | GSE1419_DOC | ||
| GSE1423 | Global analysis of genes differentially expressed in branching and non-branching regions of the mouse embryonic lung | 15328023 | GSE1423_DOC | ||
| GSE1435 | Microarray Based Comparison of two Amplification Methods For Nanogram Amounts of Total RNA | 15613496 | GSE1435_DOC | ||
| GSE1437 | F9 cells after exposure to RA or TSA | 15467438 | GSE1437_DOC | ||
| GSE1448 | Engagement of TCR with antibodies | 15661827 | GSE1448_DOC | ||
| GSE1457 | CxVB3 infection and cardiac function | GSE1457_DOC | |||
| GSE1458 | Pioglitazone, rosiglitazone and troglitazone treatment | 15217816 | GSE1458_DOC | ||
| GSE1459 | LPS effects on macrophages | 15640147 | GSE1459_DOC | ||
| GSE1463 | Extraocular, hindlimb, and cardiac muscles, comparison of dko and mdx mice (Porter lab) | 16525850 | GSE1463_DOC | ||
| GSE1468 | Hepatic reductase null | GSE1468_DOC | |||
| GSE1471 | Cardiac muscle, comparisons of wild type and mdx mice, 8 week and 10.5 month (Porter lab) | GSE1471_DOC | |||
| GSE1472 | Extraocular and hindlimb muscle, comparison of wild type and mdx mice, 56 days (Porter lab) | 11823445 | GSE1472_DOC | ||
| GSE1479 | C57BL/6 Benchmark Set for Early Cardiac Development | GSE1479_DOC | |||
| GSE1482 | Murine Neurofibromatosis | GSE1482_DOC | |||
| GSE1552 | gene activation by IFNs in wild type and Pias1 null BMMs | 15311277 | GSE1552_DOC | ||
| GSE1555 | Vehicle and sAPPalpha-treated hippocampal slice cultures | 15342738 | GSE1555_DOC | ||
| GSE1556 | Control vs. APPSw mice gene expressions | GSE1556_DOC | |||
| GSE1559 | HSC 5-FU time course | 15459755 | GSE1559_DOC | ||
| GSE1565 | Ezh2 deficiency in double negative thymocytes | GSE1565_DOC | |||
| GSE1566 | Ezh2 deficient T-cell | GSE1566_DOC | |||
| GSE1569 | Keratinocytes in embryos and newborns, and Notch1 expression in newborns | 15068794 | GSE1569_DOC | ||
| GSE1571 | Muscle and Bone marrow SP and MP cells | GSE1571_DOC | |||
| GSE1576 | Subconfluent and confluent aortic endothelial cells | GSE1576_DOC | |||
| GSE1578A | Naive and memory B6.2.16 CD8 T cell(11K A and B) | 15311278 | GSE1578A_DOC | ||
| GSE1578B | Naive and memory B6.2.16 CD8 T cell(11K A and B) | 15311278 | GSE1578B_DOC | ||
| GSE1579 | Conditional activation of B-catenin in adult mouse epidermis for 0, 1, or 7 days | 15992546 | GSE1579_DOC | ||
| GSE1584 | EP - GMP | 15522951 | GSE1584_DOC | ||
| GSE1588 | 27_RA_RMA_Jan04_time_course | 15466718 | GSE1588_DOC | ||
| GSE1606 | Whole brain gene expression in X-monosomic and normal female mice | 15908953 | GSE1606_DOC | ||
| GSE1611 | Transcriptome of Ts1Cje and euploids cerebellum | 15590701 | GSE1611_DOC | ||
| GSE1621 | Differential expression of genes after 48 hrs, 10 d, and 3 wks of TAC | 15292486 | GSE1621_DOC | ||
| GSE1623 | NOD.scid, NOD, BDC2.5/NOD and BDC2.5/NOD.scid mice | 15671250 | GSE1623_DOC | ||
| GSE1624 | Murine orofacial development | GSE1624_DOC | |||
| GSE1659 | Time series of diabetes and exercise training induced expression changes in skeletal muscle of mice | 16352670 | GSE1659_DOC | ||
| GSE1674 | BPH and BPL mouse strain adrenal glands | 15882546 | GSE1674_DOC | ||
| GSE1680 | Effect of CCL3 on target ablation-induced macrophage recruitment into the olfactory epithelium | 15467013 | GSE1680_DOC | ||
| GSE1708 | Comparison of transcriptional changes in Cre infected with Vector infected alpha4-floxed MEFs | GSE1708_DOC | |||
| GSE1727 | Isolation and angiogenesis by endothelial progenitors in the fetal liver | 16099996 | GSE1727_DOC | ||
| GSE1744 | Preimplantation mouse embryo development MOE430A | 15282163 | GSE1744_DOC | ||
| GSE1745 | Preimplantation mouse embryo development MOE430B | 15282163 | GSE1745_DOC | ||
| GSE1749A | Preimplantation mouse embryo development | 15282163 | GSE1749A_DOC | ||
| GSE1749B | Preimplantation mouse embryo development | 15282163 | GSE1749B_DOC | ||
| GSE1749C | Preimplantation mouse embryo development | 15282163 | GSE1749C_DOC | ||
| GSE1772 | Soleus muscle | 16199803 | GSE1772_DOC | ||
| GSE1776 | Control and starved myotubes | 15608089 | GSE1776_DOC | ||
| GSE1791 | Effect of Neuromedin U on gene expression in murine T cells | 15585845 | GSE1791_DOC | ||
| GSE1800 | Murine Spastic Spinal Cord | GSE1800_DOC | |||
| GSE1806 | Skeletal muscle allotypes | GSE1806_DOC | |||
| GSE1809 | Cardiac grafts pteridine cyclosporinA and NIL treated | 16495807 | GSE1809_DOC | ||
| GSE1811 | response to HDI | 15885264 | GSE1811_DOC | ||
| GSE1819 | Induction of similar multistage transcriptional responses in the mouse uterus by E2 and GEN | 15289156 | GSE1819_DOC | ||
| GSE1830A | Identification of spinal cord fusimotor neuron-specific genes.Tourtellotte-5R01NS040748-03-2 | GSE1830A_DOC | |||
| GSE1830B | Identification of spinal cord fusimotor neuron-specific genes.Tourtellotte-5R01NS040748-03-2 | GSE1830B_DOC | |||
| GSE1835 | Myocilin effect on retina. Russell-7U24NS043571-02 | GSE1835_DOC | |||
| GSE1839 | Equivalence of biologic responses induced in the mouse uterus by E2, GEN, and DES | 15289156 | GSE1839_DOC | ||
| GSE1847 | Boswellia Serrata | 15539433 | GSE1847_DOC | ||
| GSE1852 | Fibrillin-1 deficient mice | 15546004 | GSE1852_DOC | ||
| GSE1867 | mouse corneal stromal cells | 15452052 | GSE1867_DOC | ||
| GSE1871 | SCCOR_MouseLung_Simva_LPS | 15665042 | GSE1871_DOC | ||
| GSE1873 | The effect of intermittent hypoxia on gene expression in the liver of ob/ob mice | 16037401 | GSE1873_DOC | ||
| GSE1886 | Murine Müllrian duct Day0 DES | GSE1886_DOC | |||
| GSE1899 | Targets of Wnt-1 in C57MG | 15794748 | GSE1899_DOC | ||
| GSE1906 | LPS induced gene expression in macrophages in the presence of Carbon monoxide | GSE1906_DOC | |||
| GSE1912 | Gene expression profiles of mouse back skin during the hair growth cycle | 15520371 | GSE1912_DOC | ||
| GSE1921 | Homeostatic Proliferation of OT-I T cells | 15548615 | GSE1921_DOC | ||
| GSE1936A | Epididymal fat tissues-DU6/DU6i-DUKs/DBA | GSE1936A_DOC | |||
| GSE1936B | Epididymal fat tissues-DU6/DU6i-DUKs/DBA | GSE1936B_DOC | |||
| GSE1940 | LGG treatment on YANC | 16306130 | GSE1940_DOC | ||
| GSE1947 | Disease mechanisms in peripheral neuropathies due to altered Pmp22 gene dosage or a Pmp22 point mutation | 15755691 | GSE1947_DOC | ||
| GSE1948 | SRF-VP16 overexpression in ES cells | GSE1948_DOC | |||
| GSE1949 | Time series serum stimulation of ES cells of different Srf genotype | GSE1949_DOC | |||
| GSE1956 | Mouse neuroblastoma Tcof1 | GSE1956_DOC | |||
| GSE1984 | Skeletal muscle cell differentiation | GSE1984_DOC | |||
| GSE1986 | Global gene expression across a range of tissues | GSE1986_DOC | |||
| GSE1988 | Exercise and transcriptional analysis in male eNOS Knockout Mice | 15879487 | GSE1988_DOC | ||
| GSE1998A | Genes regulated by Egr3 in primary myotubes. Tourtellotte-5R01NS040748-03 | GSE1998A_DOC | |||
| GSE1998B | Genes regulated by Egr3 in primary myotubes. Tourtellotte-5R01NS040748-03 | GSE1998B_DOC | |||
| GSE1999 | Neuroprotective effects of erythropoietin. Wilson-5R01NS028208-15 | GSE1999_DOC | |||
| GSE2002 | CstF-64 Influenced Gene Expression | 16207706 | GSE2002_DOC | ||
| GSE2005 | Hippocampus of HuD overexpressor mice. Perrone-Bizzozero-5R01NS030255-12 | GSE2005_DOC | |||
| GSE2019 | Microarray Based Comparison of three Amplification Methods For Nanogram Amounts of Total RNA | 15613496 | GSE2019_DOC | ||
| GSE2031 | Identification of genes and quantitative trait loci (QTL) that control hematopoietic stem cell functioning | GSE2031_DOC | |||
| GSE2039 | FACS purified cortical projection neurons | GSE2039_DOC | |||
| GSE2042A | Apoptosis and differentiation commitment:novel insights revealed by gene profiling studies in mouse Embryonic Stem cells | 16311515 | GSE2042A_DOC | ||
| GSE2042B | Apoptosis and differentiation commitment:novel insights revealed by gene profiling studies in mouse Embryonic Stem cells | 16311515 | GSE2042B_DOC | ||
| GSE2057 | Gene expression profiling and localization of Hoechst-effluxing CD45- and CD45+ cells in the Embryonic Mouse Lung | 16076931 | GSE2057_DOC | ||
| GSE2059 | IL-21/IL-15 regulation of CD8 T-cells | GSE2059_DOC | |||
| GSE2060A | Characterize CREB target genes in different tissue types | 15753290 | GSE2060A_DOC | ||
| GSE2060D | Characterize CREB target genes in different tissue types | 15753290 | GSE2060D_DOC | ||
| GSE2082 | ER stress time course (WT vs CHOP-/-) | 15601821 | GSE2082_DOC | ||
| GSE2084A | Effect of radiation on Oct-1 mutant and Wild Type Mouse strains | 16322220 | GSE2084A_DOC | ||
| GSE2084B | Effect of radiation on Oct-1 mutant and Wild Type Mouse strains | 16322220 | GSE2084B_DOC | ||
| GSE2118 | IR-response in Atm-/- and control lymph nodes | 16314843 | GSE2118_DOC | ||
| GSE2120 | Growth Hormone (GH) Treatment of 3T3-F442A Adipocytes | 16326703 | GSE2120_DOC | ||
| GSE2121 | Skeletal muscle of adrenalectomized mice with and without a glucocorticoid injection 3 or 24 h previously (MG-U74Av2) | 15716308 | GSE2121_DOC | ||
| GSE2123A | FDC-E vs FDC-D | 15843551 | GSE2123A_DOC | ||
| GSE2123B | FDC-E vs FDC-D | 15843551 | GSE2123B_DOC | ||
| GSE2123C | FDC-E vs FDC-D | 15843551 | GSE2123C_DOC | ||
| GSE2124A | sLTbetaR-Ig treated mLN | 15843551 | GSE2124A_DOC | ||
| GSE2124B | sLTbetaR-Ig treated mLN | 15843551 | GSE2124B_DOC | ||
| GSE2195 | Phenotypic Anchoring of Gene Expression Changes during Estrogen-Induced Uterine Growth | 15598610 | GSE2195_DOC | ||
| GSE2528 | Comparative Analysis of MMTV-neu tumors, preneoplastic MMTV-neu mammary gland, and Wild-type controls | 15897883 | GSE2528_DOC | ||
| GSE272A | T and B lymphocyte development profiles | 12538694 | GSE272A_DOC | ||
| GSE272B | T and B lymphocyte development profiles | 12538694 | GSE272B_DOC | ||
| GSE4140 | NF639 cells original population vs EGCG-resistant population | 16707458 | GSE4140_DOC | ||
| GSE5317 | Expression analysis of Day 0 versus Day 1 involuting mouse mammary gland | GSE5317_DOC | |||
| GSE6439 | OVX/P4&oil/UTX 129 WT vs. Hoxa-10-/- | GSE6439_DOC | |||
| GSE6440 | OVX/P4/UTX 129/SvImJ WT | GSE6440_DOC | |||
| GSE6821A | Global gene expression analysis of GMP from Icsbp (Irf-8) deficient mice | GSE6821A_DOC | |||
| GSE6821B | Global gene expression analysis of GMP from Icsbp (Irf-8) deficient mice | GSE6821B_DOC | |||
| GSE97 | Large-scale analysis of the mouse transcriptome | 11904358 | GSE97_DOC | ||
| BASIC 21 | GSE11 | NOD model of type 1 diabetes | 11827943 | GSE11_DOC | |
| GSE12 | Group1 | GSE12_DOC | |||
| GSE1284 | Control | GSE1284_DOC | |||
| GSE1285 | Hindlimb suspension | GSE1285_DOC | |||
| GSE1286 | Reloaded 1 day | GSE1286_DOC | |||
| GSE1287 | Reloaded 7 days | GSE1287_DOC | |||
| GSE1293 | Hindlimb suspension and reloading study | 15479860 | GSE1293_DOC | ||
| GSE1367 | Simulated Microgravity Inhibits Differentiation and Alters Gene Expression Profiles of 2T3 Pre-osteoblasts | GSE1367_DOC | |||
| GSE15 | Group2 | GSE15_DOC | |||
| GSE1503 | Male/Female BALB/c Mouse Submandibular/Sublingual/Parotid/Lacrimal/Meibomian Glands | 15668334 | GSE1503_DOC | ||
| GSE1536 | Various mouse cell lines and tissues | GSE1536_DOC | |||
| GSE1582 | Male BALB/c Mouse Testosterone-Treated Submandibular/Lacrimal/Meibomian Glands | 16186348 | GSE1582_DOC | ||
| GSE1678 | H2O2 treatment of myotubes | 15331678 | GSE1678_DOC | ||
| GSE1679 | Isometric contractions in skeletal muscle of adult mice | 15331678 | GSE1679_DOC | ||
| GSE1856 | Gene Analysis of Rasagiline | GSE1856_DOC | |||
| GSE1903 | Mouse tissue comparison | 15588312 | GSE1903_DOC | ||
| GSE2054 | Quantitative microarray profiling of alternative splicing in mouse tissues | GSE2054_DOC | |||
| GSE2066 | Genes regulated by FGF2 in mouse cortical neuron culture | GSE2066_DOC | |||
| GSE2168 | Mouse Immune system | 15504237 | GSE2168_DOC | ||
| GSE2178 | Mouse Expression DB 2001 CHMC | 15126645 | GSE2178_DOC | ||
| GSE2384 | Normoxia versus hypoxia exposure | GSE2384_DOC | |||
| COUNTS 30 | GSE1067 | MPSS analysis of mouse BLK CL.4 and liver cells | GSE1067_DOC | ||
| GSE1090 | Mouse cerebellum | 15246995 | GSE1090_DOC | ||
| GSE1091 | Adipose tissue of gonadectomized mice injected with dihydrotestosterone | 15525599 | GSE1091_DOC | ||
| GSE1316 | IL-10-conditioned dendritic cells elicit innate inflammatory gene products in response to danger signals | 14764687 | GSE1316_DOC | ||
| GSE1445 | Effect of potassium-depleted diet on kidney | 15238618 | GSE1445_DOC | ||
| GSE1446 | Control vs. AngII Infusion: Heart | 15242839 | GSE1446_DOC | ||
| GSE1465 | uranyl nitrate exposure | 15598614 | GSE1465_DOC | ||
| GSE1581 | MPSS mouse transcriptome analysis project | GSE1581_DOC | |||
| GSE1689 | Normal and injured liver sinusoidal endothelial cells | 15464976 | GSE1689_DOC | ||
| GSE1771 | Luteinisation genes | 15459113 | GSE1771_DOC | ||
| GSE1939 | Adult mouse testis | 15748293 | GSE1939_DOC | ||
| GSE1962 | mouse sciatic nerve profile of CMT1A peripheral neuropathy model, caused by PMP22 overexpression | 15672449 | GSE1962_DOC | ||
| GSE205 | Mouse T helper cell clones | 11801640 | GSE205_DOC | ||
| GSE206 | CD4/CD25 subsets of mouse spleen | 12023351 | GSE206_DOC | ||
| GSE2070 | SAGE: unfertilized eggs | GSE2070_DOC | |||
| GSE2122 | Skeletal muscle of glucocorticoid deprived and treated mice by SAGE | 15716308 | GSE2122_DOC | ||
| GSE348 | SAGE analysis of mouse brain regions | 12840043 | GSE348_DOC | ||
| GSE352 | Cerebellum of Lurcher (Lc +/-) mouse. | GSE352_DOC | |||
| GSE366 | Somatic cells in testes | 12748123 | GSE366_DOC | ||
| GSE42 | P19 embryonic carcinoma (EC) cells induced to form cardiomyocytes in vitro | 12204248 | GSE42_DOC | ||
| GSE4729 | The kidney collecting duct acid-base regulon | 16868073 | GSE4729_DOC | ||
| GSE504 | Comparative molecular analysis of developing mouse forelimbs and hindlimbs | 11591645 | GSE504_DOC | ||
| GSE606 | Control vs. AngII Infusion | 14570981 | GSE606_DOC | ||
| GSE652 | Chondrogenesis in ATDC5 cells | GSE652_DOC | |||
| GSE678 | Transcriptome of a mouse kidney cortical collecting duct cell line: effects of aldosterone and vasopressin | 11226305 | GSE678_DOC | ||
| GSE683 | Gene expression profiles in normal and Otx2-/- early gastrulating mouse embryos | 11114168 | GSE683_DOC | ||
| GSE786 | short and long attack latency mice | 12542675 | GSE786_DOC | ||
| GSE828 | genes/pathways underlying lipoprotein homeostasis | 11742874 | GSE828_DOC | ||
| GSE887 | Mus musculus cornea experiment | 14744882 | GSE887_DOC | ||
| MMEST | Tissue break-down of ESTs derived from Unigene clusters | 8849440 | MMEST_DOC | ||
| CUSTOM | GSE1133C | tissue-specific pattern of mRNA expression | 15075390 | GSE1133C_DOC | |
| DUAL 94 | GSE1013 | Gene Expression Profile of NHE1 Null Mutation | 15306696 | GSE1013_DOC | |
| GSE1014 | B cell response to CD40, Anti-IgM, ELC, IL4, terbutaline and lipopolysaccharide treatment | GSE1014_DOC | |||
| GSE1019 | B cell response to Anti-IgM and CD40 treatment | GSE1019_DOC | |||
| GSE1020 | B cell response to Anti-IgM and ELC treatment | GSE1020_DOC | |||
| GSE1021 | B cell response to Anti-IgM and terbutaline treatment | GSE1021_DOC | |||
| GSE1022 | B cell response to CD40 and lipopolysaccharide treatment | GSE1022_DOC | |||
| GSE1023 | B cell response to CD40 and IL4 treatment | GSE1023_DOC | |||
| GSE1024 | B cell response to ELC and lipopolysaccharide treatment | GSE1024_DOC | |||
| GSE1038 | In vivo LPS effects on cardiac endothelial RNA-15K cDNA array | 15319271 | GSE1038_DOC | ||
| GSE1042 | Cardiac endothelial in vivo responses to LPS | 15319271 | GSE1042_DOC | ||
| GSE1043 | In vitro LPS response of SVEC cells | 15319271 | GSE1043_DOC | ||
| GSE1044 | Endothelial in vivo vs. in vitro responses to LPS | 15319271 | GSE1044_DOC | ||
| GSE1058 | Reduced atherosclerosis in MyD88 null mice | 15034566 | GSE1058_DOC | ||
| GSE1098 | Effect of LPS and LPS-binding protein treatment on RAW 264.4 cells | 16982864 | GSE1098_DOC | ||
| GSE1099 | Effect of LPS and LPS-binding protein treatment for 1 hour on RAW 264.4 cells | GSE1099_DOC | |||
| GSE1100 | Effect of LPS and LPS-binding protein treatment for 2 hours on RAW 264.4 cells | GSE1100_DOC | |||
| GSE1101 | Effect of LPS and LPS-binding protein treatment for 4 hours on RAW 264.4 cells | GSE1101_DOC | |||
| GSE1102 | Effect of LPS and LPS-binding protein treatment for 8 hours on RAW 264.4 cells | GSE1102_DOC | |||
| GSE1103 | Effect of LPS and LPS-binding protein treatment for 16 hours on RAW 264.4 cells | GSE1103_DOC | |||
| GSE1104 | Effect of LPS and LPS-binding protein treatment for 48 hours on RAW 264.4 cells | GSE1104_DOC | |||
| GSE1109 | CEA_SGF:E00002#REtsAF-Bcl2_ZVAD | 15326223 | GSE1109_DOC | ||
| GSE1129 | Rb knockout retinal explant comparison | 14991054 | GSE1129_DOC | ||
| GSE1138 | Gene expression in mouse ovary and testis | 15156144 | GSE1138_DOC | ||
| GSE1150 | CEA_SGF:E00005#LIF | 16099994 | GSE1150_DOC | ||
| GSE1151 | CEA_SGF:E00004#TetOFF_Stat3F | 16099994 | GSE1151_DOC | ||
| GSE1290 | CEA_SGF:E00008#transgenic_IIb-tk | 15947096 | GSE1290_DOC | ||
| GSE1298 | Aquaporin-1 Knockout vs Wild type Mice | 15507545 | GSE1298_DOC | ||
| GSE1348 | HBC-3 matrigel differentiation | GSE1348_DOC | |||
| GSE1393A | A time course microarray study of gene expression in the mouse lacrimal gland after acute corneal trauma. | 15671270 | GSE1393A_DOC | ||
| GSE1393B | A time course microarray study of gene expression in the mouse lacrimal gland after acute corneal trauma. | 15671270 | GSE1393B_DOC | ||
| GSE1405 | LPS-induced and E. coli-induced gene expression in wildtype and MyD88-/- mouse macrophages | 15367722 | GSE1405_DOC | ||
| GSE1438 | Differential Gene Expression due to direct effects of IL-13 on Airway Epithelial Cells | 16083784 | GSE1438_DOC | ||
| GSE1467 | PancChp-HSLKO and WT | GSE1467_DOC | |||
| GSE1498 | Mammary carcinomas in c-Myc transgenic mice | GSE1498_DOC | |||
| GSE1506 | A404 Smooth Muscle Cell Differentiation | 15340120 | GSE1506_DOC | ||
| GSE1533 | In vivo selection of diverging tumor phenotypes | GSE1533_DOC | |||
| GSE1560 | Aortas of mice on high fat diet | 15550693 | GSE1560_DOC | ||
| GSE1564 | Electrical pacing of mouse muscle | GSE1564_DOC | |||
| GSE1574 | Time-course of mdx and wild type mice | GSE1574_DOC | |||
| GSE1580 | Analysis of murine epididymal adipose tissue | 15888570 | GSE1580_DOC | ||
| GSE1596 | Retinoic acid-induced neuroblastoma cells | GSE1596_DOC | |||
| GSE1597 | Differentiated vs undifferentiated neural stem cells | GSE1597_DOC | |||
| GSE1598 | Embryonic E14.5 telencephalon vs adult forebrain | 16107646 | GSE1598_DOC | ||
| GSE1636 | A multigene analysis of the effects of L-arginine treatment in the hindlimb and diaphragm muscles of mdx mice. | GSE1636_DOC | |||
| GSE1701 | Mouse Expression Database | GSE1701_DOC | |||
| GSE1742 | TGFbeta signalling in fibroblasts. | 15769904 | GSE1742_DOC | ||
| GSE1826 | Dexamethasone treatment of gut cells | 15826934 | GSE1826_DOC | ||
| GSE1840 | Identification of central nervous system genes involved in the host response to the scrapie agent. | 15483264 | GSE1840_DOC | ||
| GSE1863 | Dual Ligand Effects | GSE1863_DOC | |||
| GSE1897 | Mouse Hepatocellular Carcinoma Study | 15565109 | GSE1897_DOC | ||
| GSE1954 | CX43 heterozygous, Cx43 null and Cx32 null vs wildtype neonatal mouse brain | GSE1954_DOC | |||
| GSE1961 | Connexin43 null vs wildtype neonatal mouse HEART | 15585606 | GSE1961_DOC | ||
| GSE2001 | Skeletal Muscle Response | 16081620 | GSE2001_DOC | ||
| GSE2008 | Expression profiling of liver tissue from C57BL6 x DBA strain | 12646919 | GSE2008_DOC | ||
| GSE2050 | Major Patterns of B Cell Gene Expression Changes in Response to Short-Term Stimulation with 33 Single Ligands | 15585835 | GSE2050_DOC | ||
| GSE2083 | Microarray analysis of the fiber cell maturation in the lens | GSE2083_DOC | |||
| GSE2090 | Endothelial cells and exposure to enviromental tobacco | 15728332 | GSE2090_DOC | ||
| GSE2098 | A distinct and unique M2 transcriptional program expressed by tumor-associated macrophages | 16269622 | GSE2098_DOC | ||
| GSE2112 | Mouse Models for Muscular Dystrophy | 16306063 | GSE2112_DOC | ||
| GSE2464 | Spleen vs Neurokinin B (NEB) Treated B cell | GSE2464_DOC | |||
| GSE3165B | Identification of conserved gene expression features across human and murine mammary tumors murine mammary tumors | GSE3165B_DOC | |||
| GSE370 | Spleen vs 2-Methyl-thio-ATP Treated B cell | GSE370_DOC | |||
| GSE371 | Spleen vs Anti-IgM Treated B cell | GSE371_DOC | |||
| GSE372 | Spleen vs BAFF Treated B cell | GSE372_DOC | |||
| GSE373 | Spleen vs BLC Treated B cell | GSE373_DOC | |||
| GSE374 | Spleen vs Bombesin Treated B cell | GSE374_DOC | |||
| GSE375 | Spleen vs CD27 Treated B cell | GSE375_DOC | |||
| GSE376 | Spleen vs CD40 Treated B cell | GSE376_DOC | |||
| GSE377 | Spleen vs CGS Treated B cell | GSE377_DOC | |||
| GSE378 | Spleen vs CpG-oligodeoxynucleotide Treated B cell | GSE378_DOC | |||
| GSE379 | Spleen vs Dimaprit Treated B cell | GSE379_DOC | |||
| GSE380 | Spleen vs ELC Treated B cell | GSE380_DOC | |||
| GSE381 | Spleen vs fMLP Treated B cell | GSE381_DOC | |||
| GSE382 | Spleen vs GHRH Treated B cell | GSE382_DOC | |||
| GSE383 | Spleen vs IFN beta Treated B cell | GSE383_DOC | |||
| GSE384 | Spleen vs IFN gamma Treated B cell | GSE384_DOC | |||
| GSE385 | Spleen vs Insulin-like growth factor 1 gamma Treated B cell | GSE385_DOC | |||
| GSE386 | Spleen vs IL4 Treated B cell | GSE386_DOC | |||
| GSE387 | Spleen vs IL10 Treated B cell | GSE387_DOC | |||
| GSE388 | Spleen vs Lysophosphatidic Acid Treated B cell | GSE388_DOC | |||
| GSE389 | Spleen vs Lipopolysaccharide (LPS) Treated B cell | GSE389_DOC | |||
| GSE390 | Spleen vs Leukotriene B4 (LTB4) Treated B cell | GSE390_DOC | |||
| GSE391 | Spleen vs MIP3-alpha Treated B cell | GSE391_DOC | |||
| GSE392 | Spleen vs NGF (Nerve Growth Factor) Treated B cell | GSE392_DOC | |||
| GSE393 | Spleen vs Neuropeptide Y Treated B cell | GSE393_DOC | |||
| GSE394 | Spleen vs Platelet activating factor Treated B cell | GSE394_DOC | |||
| GSE395 | Spleen vs Prostaglandin E2 Treated B cell | GSE395_DOC | |||
| GSE396 | Spleen vs Sphingosine-1-phosphate Treated B cell | GSE396_DOC | |||
| GSE397 | Spleen vs SDF1 alpha (Stromal cell derived factor-1) Treated B cell | GSE397_DOC | |||
| GSE398 | Spleen vs SLC (Secondary lymphoid-organ chemokine) Treated B cell | GSE398_DOC | |||
| GSE399 | Spleen vs Terbutaline Treated B cell | GSE399_DOC | |||
| GSE400 | Spleen vs TGF-beta (transforming growth factor-beta) Treated B cell | GSE400_DOC | |||
| GSE401 | Spleen vs Tumor necrosis factor-alpha Treated B cell | GSE401_DOC | |||
| GSE402 | Spleen vs Untreated, cultured B cell | GSE402_DOC | |||
| Human 642 | GSE3398 | Diversity of gene expression in adenocarcinoma of the lung. | 11707590 | GSE3398_DOC |